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Abstract 
A review of the literature revealed the need for further analysis of the impact of 
advanced electronic health record (EHR) use on medication error rates within US 
hospitals. A retrospective cross-sectional patient level analysis using the combined 2009 
data from the National Inpatient Sample (NIS), Health Information Management Systems 
Society (HIMSS) Analytics, and American Hospital Association (AHA) annual survey 
datasets was conducted to study the relationship between advanced electronic health 
record use and medication error rates. 
 A random sample of 1,032,905 patient cases was selected. A total of 
301,289 (29.2%) patient cases originated from hospitals with advanced EHR. A total of 
550 hospitals were included in the analysis, with 104 (18.9%) reporting use of advanced 
EHR. Compared to patient cases from hospitals without advanced EHR, those with 
advanced EHR had a lower proportion of medication errors (6.7% vs. 6.3%, p < 0.0001). 
There was only a small difference in the assumed direction to begin with, but it remained 




statistically significant when using the matched sample. This indicates that the small 
statistically significant difference revealed in the initial analyses may have been due to 
selection bias. While use of advanced EHRs has great potential for improving a variety of 
health and safety matters in the hospital, it is possible that its current implementation has 
not evolved enough to have an effect. Technology alone will not solve the problem, but it 
can be a part of the solution. We must establish a total systems approach to problem of 








Background and Need 
Patient safety has emerged as a central measure of quality in today’s healthcare 
environment that has far-reaching impact on various aspects in the continuum of care. 
The practice of patient safety has been defined as those practices that reduce the risk of 
adverse events related to exposure to medical care across a range of diagnoses or 
conditions (Shojania et al., 2001). The Institute of Medicine (IOM) defines patient safety 
as the prevention of harm to patients (Berkowitz et al., 2012) and places it under the 
overarching umbrella of quality measures in healthcare (Kohn et al., 2000). Emphasis is 
placed on the system of care delivery that (1) prevents errors, (2) learns from the errors 
that do occur, and (3) is built on a culture of safety that involves health care 
professionals, organizations, and patients (Aspden, 2004). The Agency for Healthcare 
Research and Quality's (AHRQ) Patient Safety Network website expands upon the 
definition of prevention of harm, describing it as freedom from accidental or preventable 
injuries produced by medical care (AHRQ, 2007).  
IOM conducted a landmark study in 1999 on medical errors and found that 
medical errors lead to the deaths of between 44,000 and 98,000 people in US hospitals 
each year (JHITA, 2000). The Journal of the American Medical Association gives a more 
conservative estimate and states that between 5,000 and 15,000 of those deaths were 
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preventable (Gillespie, 2002). One type of medical error is adverse drug events (ADEs), 
which are a subset of those injuries associated with errors that occur during the ordering, 
administering, dispensing, and monitoring of drugs (Wolfstadt et al, 2008). ADEs 
increase morbidity, and health care costs.  
In addition to their impact on patient mortality, ADEs exact other significant 
costs. They have been estimated to result in higher costs due to additional care 
necessitated by the errors, lost income and household productivity, and disability of 
between $17 billion and $29 billion per year in hospitals nationwide (JHITA, 2000). The 
impact of medication errors is also felt when patients lose trust in the health care system 
and when both patients and health professionals experience reduced satisfaction. Patients 
who experience a long hospital stay or disability as a result of errors experience physical 
and psychological discomfort. Health professionals pay with loss of morale and 
frustration at not being able to provide the best care possible. Society bears the costs of 
errors as well, in terms of lost worker productivity, reduced school attendance by 
children, and poorer population health (Kohn et al., 2000).  
A number of factors contribute to medication errors. One of the most challenging 
but preventable factors is the decentralized and fragmented nature of the healthcare 
delivery system. When patients see multiple providers in different settings, none of whom 
have access to complete information, it becomes easier for errors to occur (Kohn et al., 
2000).  
Historically, most third-party purchasers of healthcare provided little financial 
incentive for health care organizations and providers to improve safety and quality (Kohn 
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et al., 2000). Pay for Performance is changing the way Medicare pays for hospital care by 
rewarding hospitals for delivering services of higher quality and higher value (Cromwell 
et al., 2011). The program is an umbrella term for initiatives aimed at improving the 
quality, efficiency, and overall value of health care. In some Pay for Performance models, 
payers consider information technology critical to improving the coordination, quality, 
and efficiency of care. In such a measure, payers might reward organizations for the use 
of an EHR to order prescriptions for their patients, a process that can both lower costs 
and improve quality by reducing medication errors (Cromwell et al., 2011). 
Many patient safety practices that are tied to information technology, such as use 
of simulators, bar coding, computerized physician order entries, and crew resource 
management, which have been considered as possible strategies to avoid patient safety 
errors and improve healthcare processes. Although not all adverse events in healthcare 
are preventable, IOM concluded that many could be avoided through better professional 
practices, more effective teamwork, and new technology (Berkowitz et al., 2012). EHRs 
that use computerized physician order entry (CPOE) with clinical decision support (CDS) 
have been promoted as an effective strategy to prevent the development of a drug injury 
defined as an adverse drug event (ADE) (Wolfstadt et al., 2008). CDS is a technology 
that provides clinicians with real-time feedback about a wide range of diagnostic and 
treatment-related information as they are entering electronic orders. By running 
electronic rules in the background, decision support can check for a variety of potential 
errors such as drug interactions, patient allergies to prescribed medications, medication 
contraindications, and renal- and weight-based dosing. For a number of years, 
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organizations such as the Institute of Medicine and Leapfrog have been calling for 
implementation of advanced EHRs, and CPOE in particular, (Milstein et al., 2000). 
Efforts have been underway for nearly 50 years to implement EHR systems. The 
pace of change has greatly accelerated since the passage of the Health Information 
Technology for Economic and Clinical Health Act (HITECH) which is part of the 
American Reinvestment & Recovery Act (ARRA) of 2009. This is an effort to transform 
healthcare delivery through widespread adoption and use of EHR technology. 
Meaningful Use is an incentive program authored by the Centers for Medicare & 
Medicaid Services (CMS) that provides eligible hospitals and professionals with financial 
incentives to implement EHR systems and demonstrate “meaningful use” of certified 
systems.   
HITECH proposes the meaningful use of interoperable EHRs throughout the 
health care delivery system as a critical national goal. The concept of Meaningful Use 
rests on five pillars of health outcomes policy priorities, namely: (1) improving quality, 
safety, efficiency, and reducing health disparities; (2) engaging patients and families in 
their own healthcare, (3) improving care coordination, (4) improving population and 
public health, and (5) ensuring adequate privacy and security protection for personal 
health information (CMS.gov).  
By providing incentives to individual providers for using EHR systems in specific 
ways, CMS has motivated a fragmented customer base to behave more like a single 
customer with coherent demands. In effect, CMS, as a behind-the-scenes customer, is 
driving standardization and the resulting economies of scale and scope in the EHR field 
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in the same way that large industry players have been able to standardize and draw value 
from IT use in banking, retail merchandising, airlines, food services, and other sectors of 
the economy. Understanding that markets are often slow to respond to customer demand, 
and that EHR purchasers have limited ability to evaluate the quality of EHR vendor 
products prior to purchase, HITECH also created federal certification of EHR products. 
This certification gives a degree of assurance to providers and CMS about the quality of 
EHR products they purchase (healthit.gov). 
The Meaningful Use incentive program was established with three phases: Stage 
1, Data Capture and Sharing; Stage 2, Advanced Clinical Processes; and Stage 3, 
Improved Outcomes (see Table 1). Stage 1 of the Meaningful Use program focuses 
primarily on promoting consistency of documentation in terms of what data should be 
captured (content) and how it should be presented (structure). It does not address in detail 
how data should be recorded (vocabulary) (healthit.gov). Stage 1 also links 
documentation requirements with measurement and decision support requirements to 
ensure that the data being captured are more than just a description of observations, 
diagnoses, and treatments for future reference; clinicians now had the systems and the 
motivation to document in ways that would allow EHR systems to be tools for enhanced 
decision-making.  
In terms of interoperability of systems, Stage 1 focuses on promoting inter-
organization electronic transactions that were already gaining acceptance in the market, 
such as e-prescribing, lab results delivery, and public health reporting. It also laid the 
foundation for new types of transactions, specifically EHR-to-EHR transactions, by 
requiring that systems be able to generate electronic record extracts that can be read by 
6 
 
other systems. The ability to electronically send, receive, and incorporate such extracts 
from other EHR systems was left for more advanced stages. 
In Stage 2, Meaningful Use requires hospitals and health care providers to meet 
more advanced requirements to qualify for incentives during this stage, and specifies 
what criteria electronic health records must meet to achieve certification. Specific to 
Stage 2, the capability to submit electronic data about immunizations is in the core set of 
criteria for eligible professionals (EPs), as are the capability to submit electronic data for 
immunizations, reportable laboratory results, and syndromic surveillance. In addition, 
two new public health objectives for EPs have been added to the menu set, requiring the 
capability to 1) identify and report cancer cases to a cancer registry and 2) identify and 
report non-cancer cases to specialized registries. 
Stage 2 further refines the notion of system-neutral records by taking EHR-to-
EHR interoperability further and requiring not just common structures (consolidated 
Clinical Document Architecture (CDA)) and common content (problems, labs, 
medications, etc.), but use of specific vocabularies as well, such as SNOMED CT, 
LOINC, and RxNORM, to enable cross-system understanding of clinical information 
from one organization to another. And while Stage 1 simply requires that systems be able 
to generate standardized clinical documents, Stage 2 requires that they be able to 
transport clinical information from one system to another. 
Stage 3 rules were announced in October 2015, making significant changes 
intended to ease the reporting burden on all providers, support health information 
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exchange, and improve patient outcomes. One important change is a shift in focus so that 
health IT becomes a tool for care improvement, not an end in itself. 
While each stage of Meaningful Use has sent ripples of change across the EHR 
landscape in terms of functions and capabilities, each stage has also engendered evolution 
in the very definition of an EHR. While Meaningful Use is not yet complete, it is not too 
early to assess how it is already shaping the field. Setting common functional 
requirements for EHRs and incentives for users to take advantage of those functions, the 
Meaningful Use program has imposed a degree of coordination on healthcare that the 
fragmentation of the industry has prevented up until now. Meaningful Use can go only so 
far, however, as it is not robust enough to change larger and deeper trends in the industry 
that are driving business arrangements and revenue models.  
Meaningful Use has certainly been successful in creating a common floor of 
capability across vendors’ systems, which has inalterably shaped the EHR industry. It has 
also had a profound impact on the widespread adoption and use of EHR systems in 
hospitals and physician practice. 
Vendors have yet to reach plug-and-play capability with EHR systems, however, 
and it is highly unlikely that Meaningful Use will have enough influence or enough time 
to instill such capability in the market.  
Problem Statement 
There has been little research on the overall effectiveness of advanced EHRs on 
medication errors in an inpatient setting. Various studies have attempted to show the 
value of various aspects of technology on patient care, but no comprehensive research 
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had been conducted to evaluate the relationship between advanced EHR use and 
medication errors among US hospitals. This study has sought to understand the 
relationship between advanced EHR use and medication errors in US hospitals 
participating in HIMSS Analytics, a global, cause-based, not-for-profit organization 
promoting better health through information technology (IT). 
Research Question 
What is the relationship between advanced EHRs use and medication errors rates 
in HIMSS Analytics participating US hospitals? 
Hypothesis 
Hypothesis: Hospitals with advanced EHRs have lower rates of medication errors 
compared to hospitals without advanced EHRs. 
EHR Adoption Model  
EHRs in our sample was grouped by stage of use, a model previously used by 
Kazley (2014), based on individual application reported to be in use by the hospitals The 
EHR usage level was classified into four stages based on various components of an EHR 
reported to be in use at the time of reporting. These measures were grouped into 
categories to measure the level EHR functionality of each hospital in its EHR journey 
(see Table 1). This allowed us to measure the effects on medication error rates for each 
hospital as the hospital adopts additional components of an EHR. The categories we used 
are Stage 0 (no EHR applications installed), Stage 1 (EHR with ancillary services 
including a clinical data repository, pharmacy, laboratory, and radiology information 
systems), Stage 2 (Stage 1 plus EHR with nursing workflow including electronic nursing 
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documentation and medication administration records), and Stage 3 (EHR with Stage 1 
and 2 components, plus CPOE and clinical decision support). A hospital with Stage 3 
EHR has reported successful implementation all of all Stage 1 and Stage 2 applications 
plus CPOE and CDS. Teufel et al. (2012) point out that many of the functions present in 
advanced Stage 3 would be considered minimal functions required to meet Meaningful 
Use objectives. Since Stage 3 consists of more advanced automated features, Stage 3 
hospitals should possess enhanced capabilities to handle the demands of providing high 
quality care, which in turn will affect the patient safety capabilities of those hospitals. 
Sample 
The sample size was a 20% random sample of patients from hospitals using the 
combined 2009 data from the National Inpatient Sample (NIS), HIMSS and AHA 
datasets. The patients in our sample were grouped by stage of use of EHR at their 
associated hospitals, a model previously used by Kazley (2014), based on individual 
application reported to be in use by these hospitals in our sample.  
Definitions 
Key definitions in this research study are:  
1. ADE: Adverse Drug Events 
2. Advanced EHR: Advanced EHR will be classified as a hospital that has met 
Stage 3 criteria for EHR adoption and use.  
3. ARRA: The American Reinvestment & Recovery Act. 
4. CDS: Clinical Decision Support 
5. CPOE: Computerized Provider Order Entry 
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6. HITECH: The Health Information Technology for Economic and Clinical 
Health Act. 









REVIEW OF THE LITERATURE 
A comprehensive review of the available literature was conducted on previous 
studies whose topics directly related to the research topic. Studies that focused on the 
technology in healthcare were reviewed for their impact on the quality and safety of 
healthcare. We concluded our literature review by reviewing studies relating to 
meaningful use and EHR adoption to understand prior work and how it will impact this 
study. 
Patient Safety (Medication Errors) 
Approximately one quarter of all adverse events that occur in hospitals are 
adverse drug events or medication-related errors (Covell & Ritchie, 2009). Although 
healthcare providers have ethical and professional obligations to disclose adverse events, 
medication errors continue to be underreported. Consequently, little is known about the 
types of medication errors that are not reported.  
In To Err is Human, a 2002 study published by the Institute of Medicine (IOM), 
Kohn et al. (2000) estimate that as many as 98,000 people die per year from medical 
errors that occur in hospitals. Shojania et al. (2001) reviewed previously published 
studies to understand existing evidence on practices relevant to improving patient safety. 
They concluded that practices with the strongest supporting evidence are generally 
clinical interventions that decrease the risks associated with hospitalization, critical care, 
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or surgery. They also found that many patient safety practices drawn primarily from 
nonmedical fields (e.g., use of simulators, bar coding, computerized physician order 
entry, and crew resource management) deserve additional research to illuminate their 
value in the health care environment. 
Varkey & Bisping (2007) conducted a prospective trial on 104 primary care 
patients at the Mayo Clinic to investigate how to improve medication reconciliation and 
increase patient safety. Patients in Phase I received standard care. Patients in Phase II 
received the intervention reconciliation process, which consisted of (1) mailing letters 
before appointments to remind patients to bring medication bottles or updated medication 
lists to their visits, (2) verifying medications, and (3) correcting the medication list in the 
electronic medical record by the patient, and academic detailing and weekly audit and 
feedback of performance. They found that interventions resulted in an 89% decrease in 
prescription medication errors in Phase I and a 66% decrease in Phase II. Decreases in 
errors from 98% of the visits in Phase I to a decrease of 84% of the visits in Phase II were 
documented. When all medications were considered, a 98% decrease in medication errors 
was documented in Phase I, as well as an 84% decrease in Phase II. The average number 
of discrepancies per patient decreased by more than 50%, from 5.24 in Phase I to 2.46 in 
Phase II. 
To reduce the occurrence of medication-related errors, the Institute of Medicine 
(IOM) recommends implementing health information technologies in conjunction with 
other process improvements programs such as clear communication of drug information 
between the provider and patient, a team-based approach that demands the attention of 
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everyone involved, and encouraging the accrediting agencies to require training in 
medication management practices (Aspden, 2006). 
Healthcare Information Technology. 
Computerized Provider Order Entry (CPOE) are electronic orders for medication, 
laboratory and radiology services placed by a licensed healthcare professional into the 
Electronic Health Record (EHR) per state, local and professional guidelines. In using 
CPOE for medications, orders are incorporated with patient information, such as other 
prescriptions and lab results, which can be automatically checked for potential errors or 
problems. This real-time crosscheck improves optimal drug selection and reduces errors 
at the time of ordering, a safer and more effective way to order medications than using 
prescription pads or paper forms. Researchers found that 90 percent of all providers felt 
that the VA electronic prescribing system, including its order check, improved 
prescribing safety to some degree (Spina et al., 2011). It reduces the chance of selecting 
medications for which the patient has a known allergy, or drugs that are off-formulary for 
their health plan. Additionally, the medication information is updated in the patient’s 
medical record and easily available for follow-up visits. Birkmeyer (2004) estimates that 
universal implementation of CPOE would avert approximately 567,000 serious 
medication errors each year in the United States. 
While not all adverse events in healthcare are preventable, IOM concluded that 
many could be avoided through better professional practices, more effective teamwork, 
and new technology (Berkowitz, 2012). When implemented together, CPOE systems and 
CDS can improve medication safety and quality of care and reduce costs of care 
(Kaushal, 2003). The CPOE system employed a CDS element to provide clinicians with 
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access to evidence-based guidelines, prompts, and alerts at the bedside. CPOE should not 
be pursued in isolation from other technologies. Simply entering orders in a system 
without providing clinical decision support during the order-entry process may have 
limited benefit. In order to optimize impact on quality, safety, and efficiency, CPOE 
should be an integrated component of the EHR system. They can also improve 
compliance with provider guidelines, as well as the efficiency of hospital workflow 
(Dexter, 2001). Most evidence demonstrating the value of CPOE comes from research in 
hospital settings. CPOE and decision support systems (DSS) can reduce certain types of 
error (Handler et al., 2004).  
The results from a case study conducted at the University of Maryland in 2006 on 
continuous medication infusion in a pediatric ICU showed the benefit of using CPOE 
versus handwritten orders. The results indicated that a total of 234 orders were generated 
using each method by 26 physicians ordering nine drips each. Orders placed using CPOE 
required significantly less time (5.5 minutes + 2 minutes) as compared to the handwritten 
method (26 minutes + 8 minutes). In addition, use of CPOE resulted in significantly 
fewer errors: 10 of 243 drip orders (4.3%), compared to the handwritten method, where 
170 of 243 drip orders (73%) contained one or more errors. Among the handwritten 
errors, 25% were judged to be ‘high-risk’ with the potential for serious adverse effects 
(Vaidya, 2006). 
In a 2012 study, Dow et al. studied the impact of implementing CPOE on three 
elements of medication use system performance: inpatient medication override dispense 
rates from automated dispensing cabinets (ADCs), medication first-dose turnaround time 
(TAT), and pharmacists’ perceptions of the medication orders management process. 
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Their results support the positive effects of an advanced EHR on patient safety, indicating 
that after the implementation of CPOE, the relative number of medication override 
dispenses decreased by 58%. The mean time from order entry to order verification 
improved by 76%, and the mean TAT for intravenous antibiotics improved by 31%. 
Pharmacists’ overall satisfaction with the medication orders management process 
improved by 23%. Dow et al. concluded that the implementation of CPOE resulted in 
improvement in each of the three medication use system elements assessed. 
A cross sectional nationwide study conducted with Veteran Administration (VA) 
physicians on the perceptions of and experiences with order entry and order checks (drug 
alerts) in an electronic prescribing system may help improve medication safety 
technology. This study also shows systems using an advanced EHR can have a positive 
impact on patient safety. Researchers found that 90% of all providers felt that the VA 
electronic prescribing system, including its order check, improved prescribing safety to 
some degree. A significant number (88%) of physicians who encountered serious allergic 
or adverse drug reactions reported either notifying a pharmacist or entering the 
information in the allergies/adverse reactions field, and 48% of providers described 
critical drug-drug interaction alerts as very useful (Spina et al., 2011).   
Wolfstadt et al. (2008) conducted a cross-sectional retrospective study on the 
impact of CPOE with CDS on adverse drug event. The Wolfstadt study is significant to 
this study in that of the nine studies that were evaluated in a hospital setting (One study 
was done on an ambulatory care setting.), only three were conducted with hospitals with 
COPE with CDS implemented house-wide. The Wolfstadt review only included three 
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studies that used commercially sold systems, whereas seven studies used in-house 
designed systems.  
Evans et al. (1994) evaluated the prevention of ADEs with a computer alert 
program that provided alerts of drug allergies at the time of drug ordering. The study used 
a quasi-experimental pre/post design and found a significant reduction in the rate of 
ADEs due to allergic reactions from 56 in the one-year baseline period to 8 and 18 during 
two subsequent one-year study periods that incorporated CPOE with CDS (P < .002). 
There were no ADEs in years two and three of the study involving patients whose drug 
allergies were known and displayed, compared with 13 in the first year, when known 
drug allergies were not displayed. Severe ADEs were significantly reduced from 41 in the 
first study period to 12 and 15 during the two CPOE implementation periods (P < .001)  
Bates et al. (1998) assessed the effectiveness of CPOE with CDS for reducing 
preventable ADEs and demonstrated a reduction in the rates of both total ADEs and 
preventable ADEs per 1,000 patient-days. The trend in total ADEs non-significantly fell 
from 14.7 to 9.6 between the baseline and the third study period (P = .09), and the trend 
in preventable ADEs significantly decreased from 2.9 in the baseline period to 1.1 in the 
third study period (P = .05). The investigators reported a non-significant reduction of 
17% in preventable ADEs during the intervention period (P = .37). This is significant for 
our study, which will focus on preventable ADEs, in that an advanced EHR that includes 
CPOE with CDS may have a greater impact on preventable ADEs such as medication 
errors than one without it. 
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In 2011 Zlabek et al. studied the early cost and safety benefits of an inpatient 
EHR, in an inpatient setting. The study was conducted at Gundersen Lutheran Medical 
Center, a community-based tertiary referral center and teaching hospital with 325 
licensed beds and a Level 2 trauma center. During this retrospective longitudinal study, 
data were collected for the period one year before EHR (pre-EHR) and one year post-
EHR implementation. Measures of cost of care, safety, and quality for which data were 
readily available pre-EHR and post-EHR were selected and captured for all hospitalized 
patients. Their results are as follows: Medication errors per 1000 hospital days decreased 
from 17.9 to 15.4 (14.0%; p < 0.030), while near misses per 1000 hospital days increased 
from 9.0 to 12.5 (38.9%; p < 0.037), and the percentage of medication events that were 
medication errors decreased from 66.5% to 55.2% (p < 0.007). 
Jayawardena (2007) conducted a retrospective study at a Brooklyn, NY hospital 
to evaluate the efficacy of a CPOE system with the help of ancillary support in 
minimizing prescription errors. They categorized the errors as inappropriate dosage 
adjustment for creatinine clearance, duplication, incorrect orders, allergy verification, and 
incomplete orders. The pharmacists identified the type of error, the severity of error, the 
class of drug involved, and the department that made the error. A total of 466,311 
prescriptions were entered during the period of one year, and 3513 errors were identified 
during this period (7.53 errors per 1000 prescriptions). More than half of these errors 
were made by the internal medicine specialty. In this study, 50% of the errors were 
severe errors (overdosing medications with narrow therapeutic index or over-riding 
allergies), 46% were moderate errors (overdosing, wrong dosing, duplicate orders, or 
prescribing multiple antibiotics), and 4% were not harmful errors (wrong dosing or 
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incomplete orders). The errors were also categorized according to the class of medication. 
Errors in antibiotic prescription accounted for 54% of all errors. The pharmacist detected 
all of these prescription errors as the prescriptions were reviewed in the CPOE system. 
Jayawardena (2007) noted that prescription errors are common and found that the CPOE 
system can prevent and alert the prescriber and pharmacist to dosage errors and allergies. 
Involvement of the pharmacist in reviewing the prescription and alerting the physician 
has minimized prescription errors to a great degree in this hospital setting (Jayawardena, 
2007). 
Studies have shown EHR implementations, especially CPOE, have a positive 
correlation to the reduction of medication errors (Birkmeyer, 2004). The safe use of 
medications is an important area of concern within health care. On its own, CPOE has an 
impact on safety by ensuring that orders are legible, yet the value of this functionality is 
increased by adding clinical decision support (CDS) systems (Kuperman, 2003). CDS is a 
technology that provides clinicians with real-time feedback about a wide-range of 
diagnostic and treatment-related information as they are entering electronic orders. By 
running electronic rules in the background, decision support can check for a variety of 
potential errors. Examples include drug interactions, patient allergies to prescribed 
medications, medication contraindications, and renal- and weight-based dosing. An 
advanced EHR with features such as CPOE with electronic prescribing, drug interaction 
alerts, and information sharing among providers via exchanges can lead to a reduction in 
adverse events. Leapfrog also estimates that universal implementation of CPOE would 
avert approximately 567,000 serious medication errors each year in the United States 
(Birkmeyer, 2004).  
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Meaningful Use and EHR Adoption 
The Electronic Health Record (EHR) adoption rate has increased significantly 
over the past few years. 78 percent of office-based physicians report that they have 
adopted some type of EHR system. About half of all physicians (48 percent) had an EHR 
system with advanced functionalities in 2013, a doubling of the adoption rate in 2009, 
and about 59 percent of hospitals had adopted an EHR system with certain advanced 
functionalities in 2013, quadrupling the percentage for 2010 (HHS Press, 2014). 
To attain the full effect of an advanced EHR, adoption is critical in both hospital 
and physician practice setting. President Obama, following in his predecessor’s footsteps, 
first declared the goal of near universal EHR use by 2014. In the early stages of the EHR 
incentive program, approximately ten percent of hospitals and 20 percent of physicians 
were using these systems, and even fewer could meet the preliminary definition of 
meaningful use. Adoption of EHRs has been increasing at about three percent to six 
percent per year (Jha, 2010), and the widespread use of EHRs in the United States is 
inevitable. EHRs will improve caregivers’ decisions and patients’ outcomes (Blumenthal 
& Tavenner, 2010). There is wide consensus regarding the potential of health information 
technology, especially the EHR, to improve the quality and efficiency of clinical care and 
to help the nation overcome the fragmented nature of its health-care system (Burke, 
2010). 
The adoption of interoperable EHR systems could produce efficiency and safety 
savings of between $142 billion and $371 billion (Hillestad et al., 2005). In 2011 Jha et 
al. studied their adoption in US hospitals and assessed their readiness for Meaningful 
Use. The researchers in that study used data from an American Hospital Association 
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survey conducted in 2010 to measure the percentages of applicable hospitals that have 
adopted basic and comprehensive EHRs. Of the 2902 hospitals reviewed, more than 15 
percent had adopted at least a “basic” EHR, representing nearly 75 percent growth since 
2008 (Jha et al., 2011). Recent numbers released by CMS on healthit.gov suggest the 
EHR adoption rates continue to rise as the Meaningful Use incentives take effect. 
Adoption of EHR systems by non-federal acute care hospitals has steadily increased since 
HITECH. In 2013, nearly 59 percent non-federal acute care hospitals had adopted at least 
a basic EHR system with clinician notes. This represents a 34 percent increase from the 
previous year and a more than five-fold increase in EHR adoption since 2008. In 
addition, in 2013 a vast majority of acute care hospitals (93 percent) possessed EHR 
technology certified as meeting federal requirements for Meaningful Use, this is a 29 
percent increase from 2011. Hospital adoption of a Basic EHR without clinician notes has 
declined marginally, while the systems with more advanced functionality have increased 
significantly (Charles et al., 2014).  
In a 2014 study, Diana et al. studied the factors identified with hospitals achieving 
Meaningful Use criteria, using data from the 2011 American Hospital Association 
Annual Survey, including the Information Technology Supplement, the Centers for 
Medicare & Medicaid Services report of hospitals receiving meaningful use payments, 
and the Health Resources and Services Administration's Area Resource File. They found 
that 38 percent of eligible hospitals achieved Meaningful Use incentive thresholds by the 
end of 2012. The study identified characteristics associated with organizations that 
received incentive payments for having EHR in place in 2010 as a larger number of beds, 
a single health information technology vendor, Joint Commission accreditation, for-profit 
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status, Medicare share of inpatient days in the middle two quartiles, eligibility for 
Medicaid incentives, and a location in the Middle Atlantic or South Atlantic census 
region. The characteristics associated with not receiving incentive payments were 
membership in a hospital system and being located in the Mountain or Pacific census 
region. Diana et al. (2014) concluded that little evidence suggests that the HITECH 
incentive program has enticed hospitals without an EHR system to adopt Meaningful Use 
criteria. Policy makers should consider modifying the incentive program to accelerate the 
adoption of and meaningful use in hospitals without EHRs. 
Between 2008 and 2013, the number of hospitals with a Meaningful Use 
compliant EHR doubled. There was a dramatic increase in the number of hospitals that 
deployed CPOE and advanced clinical decision support (Gur-Arie, 2013). 
Summary 
A number of studies have shown that patient safety is of great concern to the 
entire healthcare community, especially to patients. Covell & Ritchie (2009) concluded 
that even though healthcare providers have ethical and professional obligations to 
disclose adverse events, medication errors continue to be underreported. Consequently, 
little is known about the types of medication errors that are not reported. Shojania et al. 
(2001) found that many patient safety practices drawn primarily from nonmedical fields 
(e.g., use of simulators, bar coding, computerized physician order entry, crew resource 
management) deserve additional research to illuminate their value in the health care 
environment. Varkey & Bisping (2007) found that interventions resulted in a decrease in 
prescription medication errors significantly. 
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In our review, healthcare information technology is shown to play a significant 
role in the delivery of care, and a number of studies show a positive correlation between 
healthcare information technology and improvement in the quality of care. Spina et al. 
found that 90 percent of all providers felt that the VA’s electronic prescribing system, 
including its order check, improved prescribing safety to some degree. CPOE with CDS 
were shown to improve patient safety, according to Kurshal et al. (2006). More evidence 
was offered by Dexter et al. that CPOE can also improve compliance with provider 
guidelines, as well as the efficiency of hospital workflows. In their 2004 study, Handler 
et al. suggest that CPOE and decision support systems (DSS) can reduce certain types of 
errors, and Birkmeyer (2004) also concluded that CPOEs have a positive correlation to 
the reduction of medication errors.  
Studies also revealed that although the level of EHR adoption has increased, the 
true impact of Meaningful Use is still to be determined. In 2010 Jha et al. found that EHR 
adoption had increased to about 75 percent since 2008. Charles et al. (2014) show that the 
number of EHRs with less advance features has declined marginally, while the number of 
systems with more advance functionality has increased significantly. In a related study, 
Diana et al. (2014) found that 38 percent of eligible hospitals had achieved Meaningful 
Use incentive thresholds by the end of 2012. A number of studies were reviewed that 
point to an increase in EHR adoption, but few or none showing the true impact of the 
Meaningful Use incentives. That may come in time as systems mature and data is 
collected on these newly implemented features. 
Overall, the review of the available literature did shine a light on the importance 
of patient safety practices and shows the impact of various parts of an EHR on patient 
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safety and quality, but nothing significant relating to how advanced EHRs are impacting 
medication errors. Our study attempts to fill this void and add to the knowledge base in 








There had been little research on the relationship between advanced EHRs and 
medication errors rates in inpatient settings, using the HIMSS Analytics participating 
hospitals as the sample population. Various studies had attempted to show the value of 
various aspects of technology on patient care, yet no comprehensive research had been 
conducted to evaluate the relationship between advanced EHRs and medication errors in 
hospitals. This study is important because the EHR adoption rate has increased 
significantly over the past few years, and to know the relationship between advance 
EHRs and medication error rates can contribute to development of strategies that can 
significantly affect quality of care. In this study, we analyzed HIMSS Analytics, AHA, 
and NIS data to evaluate the impact of using advanced EHRs on adverse events in 
healthcare, specifically comparing medication errors rates between hospitals using 
advanced EHRs (Stage 3) and hospitals not using an advanced EHR. For the purposes of 
this study, an advanced EHR necessarily included Computerized Provider Order Entry 
(CPOE) and Clinical Decision Support (CDS), which corresponds to Stage 3 EHR 
adoption. 
Study Design  
We conducted a retrospective, cross sectional patient-level study using the data 
from HIMSS Analytics for each hospital’s advanced EHR adoption scores, AHA 
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datasets, and the NIS data for the medication error rates. We analyzed the data to 
determine to what extent medication errors are affected by advance EHRs. We identified 
the independent variable as advanced EHR usage, and its effects on medication error 
rates were measured.  
Specification of Variables 
 In this study, the independent variable was advanced (Stage 3) EHR usage. The 
EHR usage level was classified into four stages based on various components of an EHR 
reported to be in use at the time of reporting. These measures were grouped into 
categories to measure the level EHR functionality of each hospital in its EHR journey 
(see Table 1). This was appropriate for our study in that it allowed us to measure the 
effects on medication error rates for each hospital as the hospital adopts additional 
components of an EHR. The categories we used are Stage 0 (no EHR applications 
installed), Stage 1 (EHR with ancillary services including a clinical data repository, 
pharmacy, laboratory, and radiology information systems), Stage 2 (Stage 1 plus EHR 
with nursing workflow including electronic nursing documentation and medication 
administration records), and Stage 3 (EHR with Stage 1 and 2 components, plus CPOE 
and clinical decision support). A hospital with Stage 3 EHR reported successful 
implementation all of all Stage 1 and Stage 2 applications plus CPOE and CDS. Teufel et 
al. (2012) point out that many of the functions present in advanced Stage 3 would be 
considered minimal functions required to meet Meaningful Use objectives. Since Stage 3 
consists of more advanced automated features, we expected Stage 3 hospitals to possess 
enhance capabilities to handle the demands of providing high quality care, which in turn 
affects the patient safety capabilities of those hospitals. 
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The dependent variable in this study was the number of medication errors found 
at participating hospitals. The results were compared to a control group of hospitals 
without advanced EHRs that were in Stages 0, 1, and 2 of EHR classification. The control 
group for non-advanced EHR represented EHRs without CPOE of CDS. We tested 
whether the experimental treatment/condition (advanced EHR) is associated with fewer 
medication errors, and whether there is sufficient evidence to support the claim that it is. 
We controlled for several hospital level variables: teaching status, urban location, bed 
count, and geographical region. Given that the patient was the unit of analysis, we also 
controlled for patient level variables: patient age, gender, race, private insurance 
coverage, Medicare and Medicaid coverage, and whether the patient arrived as a transfer. 
We also controlled for potential selection bias of advanced EHR use in hospitals and 
potential differences in patient demographics, severity of errors, and hospital case mix 
through the use of a propensity score stratification model. To calculate the propensity 
score, a logistic regression analysis was performed to estimate the likelihood of each 
patient being seen in a hospital with an advanced EHR (Table 5). Once calculated, the 
propensity score variable was added to the multivariate model to control for potential 
selection bias. Use of a propensity score approach can remove upward of 95% of bias 
from estimates (Teufel et al., 2012). 
Data Collection 
We used secondary data from the HIMSS Analytics 2009 database for hospitals in 
combination with The Healthcare Cost and Utilization Project’s (HCUP) National 
Inpatient Sample (NIS) 2009 data for patient identifiers for medication errors and AHA 
datasets. The HIMSS Analytics data were combined with demographic data from NIS to 
27 
 
measure the impact of advanced EHR use and medication error rates. NIS is a family of 
health care databases and related software products developed through a federal-state-
industry partnership and sponsored by the Agency for Healthcare Research and Quality 
(AHRQ). NIS databases bring together the data collection efforts of state data 
organizations, hospital associations, private data organizations, and the federal 
government to create a national information resource of encounter-level health care data, 
the National Inpatient Sample (NIS). NIS includes the largest collection of longitudinal 
hospital care data in the United States, with all-payer, encounter-level information 
beginning in 1988. These databases enable research on a broad range of health policy 
issues, including cost and quality of health services, medical practice patterns, access to 
health care programs, and outcomes of treatments at the national, state, and local market 
levels (AHRQ.gov). The AHA database is based on an annual survey of US hospitals that 
collects data about hospital characteristics and was used for control variables. The 
International Classification of Diseases, 9
th
 Revision, Clinical Modification (ICD-9-CM) 
codes, assigned to virtually all inpatient discharges, provides a readily available 
surveillance system capable of detecting an ADE (Table 2). The most frequently assigned 
ICD-9-CM codes are diagnosis codes, external cause of injury codes (E-codes), and 
procedure codes. In the case of an adverse drug event (ADE), a diagnosis code is used to 
indicate the patient’s general diagnosis (e.g., 693.0, dermatitis due to drugs and 
medicines taken internally), while the E-code indicates the drug class thought to be 
responsible for these symptoms (e.g., E933.1, antineoplastic and immunosuppressive 
drugs causing adverse effects in therapeutic use) (see Table 2).  
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To determine the medication error rates, we employed the model used previously 
by Hougland et al. in their 2006 study. They conducted a structured chart review and 
abstraction to identify all Adverse Events and whether a flagged ICD-9-CM code 
represented an Adverse Event. Adverse Event codes were grouped into six categories to 
facilitate analysis: adverse drug events, surgical adverse events, misadventures, 
infections, device events, and other adverse events. Our study focused on the Adverse 
Drug Events (ADE) category to measure medication errors. Hougland et al. identified 
416 ICD-9-CM codes representing ADEs (flagged ADE codes), which are represented in 
Table 2. The Hougland study concluded that flagged ADE codes have a positive 
predictive value of 25% for inpatient ADEs, and even though the flagged ADE codes 
model is imperfect, it does provide an immediately available ADE surveillance system. 
For the purposes of identifying medication errors, we measured ADE flagged 
codes associated with clinical side effects, poisoning and adverse effects (see Table 2). 
The poisoning codes for medication errors are used relatively infrequently. However, the 
poisoning codes were much more likely to detect ADEs causing admission than those 
ADEs that occurred in the hospital. Adverse effects codes are used more commonly than 
the poisoning codes (Hougland et al., 2008).  
Data Analysis 
The number of medication errors was determined for each admission by adding 
the number of ICD-9 to the number of E-codes corresponding to adverse drug effects (as 
specified in previous studies) for each patient case. (Hougland et al., 2006) Medication 
errors were categorized as clinical side effects, poisonings, and other adverse effects due 
to various agents according to methods outlined by Hougland (2006).  
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Overall means (continuous variables) and proportions (categorical variables) were 
computed. Unadjusted analyses of patient and hospital-level characteristics were assessed 
by advance EHR status using t-tests (continuous variables) and chi-squared tests 
(categorical variables). Among those with at least one medication error, the types of 
errors were compared descriptively by age, race, insurance, hospital’s number of beds, 
and hospital region  
The generalized linear models predicting the number medication errors and the 
probability of an admission originating from hospital with an advanced electronic health 
records (EHRs) (i.e. propensity model) were both controlled for the following patient 
level variables: patient age, gender, race, All Patient Diagnosis Related Groups 
(APDRGs) mortality and severity, insurance type (Medicaid, Medicare, private, other), 
neonatal or maternal status, Diagnosis Related Group (DRG) case mix group, and 
whether the patient arrived as a transfer. The following hospital-level variables were also 
controlled for in each model: teaching status, hospital location (urban vs. rural), 
hospital’s number of beds, and geographical region. Models were also weighted by 
hospital. 
A generalized linear model (binomial or logistic regression) was used to assess 
whether the proportion of patient cases reporting at least one medication error differs 
from hospitals with and without advanced EHRs. Generalized linear modeling was used 
assess whether the number of medication errors differs between hospital with and without 
advanced EHRs. Because the distribution of the number of medication errors contained 
high prevalence of zeros, a zero-inflated Poisson model (rather than the usual Poisson 
model) was used to model the total number of medication errors (see Table 4). Dependent 
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variables following a Poisson distribution are expected to have a mean equal to the 
variance. In cases of excessive zero counts, this condition is not satisfied, and over-
dispersion results. Over-dispersion can lead to an overestimate of standard errors, which 
affects the ability to determine statistical significance of covariates within the model. 
Furthermore, the underlying distribution is often a mixture of distributions including both 
a distribution predicting zeros (binomial) and a distribution predicting counts (Poisson). It 
has been demonstrated that the use of zero-inflated Poisson models can correct the 
problem of over-dispersion (Lambert, 1992).  
Two methods were used to control for selection bias. First, potential selection bias 
of advanced EHR use in hospitals and Use of a propensity score approach has been 
shown to remove upward of 95 percent of bias from estimates. (Tuefel, 2012). Potential 
differences in patient demographics, case severity, and hospital case mix were controlled 
by using propensity score stratification. The propensity score was generated by modeling 
advanced EHR use by fitting a logistic regression model and estimating the probability of 
advanced EHR for each patient case. These probabilities were stratified into quintiles, 
and the stratified variable was added to the final model associating advanced EHR with 
the outcomes of interest. Data were analyzed using SAS version 9.3, and the model was 
run using the GENMOD procedure (SAS Institute Inc., 2002-2010) (see Table 6). 
Second, potential selection bias due to case mix, patient and hospital 
characteristics were examined using propensity score matching techniques. A five 
percent random sample of the data was developed using propensity score matching based 
on the nearest neighbor-matching greedy algorithm approach. The sample was limited to 
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30,695 randomly selected observations from each group (hospitals with and without 





CHAPTER IV: FINDINGS 
 
A 20 percent simple random sample of the combined 2009 NIS and HIMSS 
datasets was utilized for this analysis. A total of 1,032,905 patient cases were selected. A 
total of 301,289 (29.2%) patient cases originated from hospitals with an advanced EHR. 
A total of 550 hospitals were included in the analysis, with 104 (18.9%) reporting use of 
advanced EHR. The total number of medication errors per patient case ranged 0-11. The 
total number of admissions with at least one medication error was 67,724 (6.6%), and the 
average number of medication errors per patient case was 0.08 (SD = 0.35) overall, 
which reflects the large number of patient cases reporting zero medication errors. The 
average number of medication errors among patient cases with at least one medication 
error was 1.27 (SD = 0.61), with an average of 1.27 (SD = 0.59) among admissions with 
advanced EHR, and 1.27 (SD = 0.62) among those without advanced EHR, p < 0.0001.  
Table 3 displays unadjusted differences in patient and hospital characteristics. All 
differences were statistically significant. The majority of covariate differences were 
small. Compared to patient cases from hospitals without advanced EHR, those with 
advanced EHR included a lower proportion of medication errors (6.7% vs. 6.3%, p < 
0.0001), were slightly younger in age, had a higher proportion of teaching hospitals and 
hospitals in urban locations. Other differences are displayed in Table 3. 
Additional unadjusted descriptive analyses of the subgroup of patient cases with 
medication errors indicated that the majority of reported medication errors were adverse 
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drug effects, while the least reported was poisonings as categorized by Hougland et al. in 
their 2006 study. Adverse drug effects were highest among the oldest age group; while 
poisonings were highest among the 18-44 year olds (see Table 2). The proportion of 
patient cases reporting clinical side effects was similar among the adult age groups. 
Among all patient cases with medication errors, White was the predominant 
race/ethnicity represented, and the most prevalent payer/insurance was Medicare, 
reflecting the demographic distribution of the patient population. Similarly, the majority 
of medication errors were among the larger sized hospitals. The largest proportion of 
patient cases reporting medication errors were from the South (31.6%), however, the 
rates by geographical region were similar for each medication error category (see Table 
3).  
Results of the zero-inflated Poisson models revealed that advanced EHR was 
positively associated with medication error, β = 0.0455 (p < 0.001), indicating that 
admissions with advanced EHRs were five percent more likely to have zero medication 
errors (OR = 1.047, 95% CI = 1.028-1.066) (see Table 4). No statistically significant 
association between the number of advanced EHRs and medication errors was detected 
from the Poisson portion of the regression model, β = 0.0095 (p = 0.2058) (see Table 5). 
Variables associated with both presence of medication error and an increased number of 
medication errors, included gender, race, risk severity, neonatal or maternal admission 
status, teaching hospital designation, urban location, geographical region of hospital, case 
mix, and propensity strata. Age was associated with a greater number of medication 
errors than were risk mortality, hospital’s number of beds, and insurance, which were 
each associated with at least one medication error. 
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Although the two-part model (zero-inflated Poisson) used to assess the association 
between advanced EHR and number of medication errors included a model for assessing 
the presence or absence of medication error, a second model was used to assess the 
second objective (to determine whether the proportion of medication errors differs in 
hospitals that do and do not use advanced EHRs). The remaining analyses focused on the 
logistic regression model because (1) statistically significant association between the 
presence of medication error and advanced EHR use were detected; (2) no statistically 
significant association between  total number of medication errors and advanced EHR use 
were detected; and (3) the high proportion of zero medication errors per patient case 
considerably lowers the overall average below 1, making the mean values uninformative, 
indicating that the more valuable indicator is presence of medication error alone. 
Controlling for propensity strata, patient and hospital characteristics in the multivariable 
logistic regression model, the proportion of medication errors among hospitals without 
advanced EHRs was 4.0%, while the proportion of medication errors among hospitals 
with advanced EHRs was 3.9% (p < 0.0001) (see Table 4). Results from both the zero-
inflated Poisson and the logistic regression models were controlled for propensity strata 
(see Table 6). 
Use of propensity score matching in the sensitivity analyses reduced the 
heterogeneity in the advanced EHR and non-advanced EHR groups as evidenced by the 
decrease in absolute standardized differences between covariates in the original dataset 
and the matched sample (see Figure 1). Using the propensity matched sample, a slightly 
higher proportion of medication errors was detected among the advanced EHR group 
however, this association was no longer statistically significant (3.7% vs. 3.6%, p = 
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0.3958). This indicates that the small statistically significant difference revealed in prior 
analyses may have been due to selection bias. 
Discussion 
The most important finding in this study is that there was only a small difference 
in the assumed direction to begin with, but it remained when using the propensity score 
stratification although the association was no longer statistically significant when using 
the matched sample. This is likely due first to the small prevalence of medication errors 
overall and second, to the early stages implementation of advanced EHRs, as our data set 
is from 2009.  
Initial analyses provided weak evidence that advanced EHR could potentially 
reduce medication error; however, sensitivity analyses indicated that this small difference 
may have been due to bias. Nearly identical estimates for the average number of 
medication errors and proportions of medication error in each group in dataset of this 
large size further indicate no difference in medication error among patient cases with and 
without advanced EHR. Additional analyses of the subgroup of patients with at least one 
medical error did not reveal differences in the average number medication errors among 
advanced and non-advanced EHR hospitals.  
While this analysis was strengthened by its use of sensitivity analyses to control 
selection bias, there are limitations. First, the data are cross-sectional, and at best only 
provide weak evidence of any association between hospitals with and without advanced 
EHR and medication error with any implication of a cause and effect relationship. 
Second, data were collected in 2009, which represented a time of EHR uptake among 
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hospitals. Thus, it is possible that even hospitals reporting advanced EHR may not have 
fully or properly implemented all elements that could have had an effect on medication 
errors. This uncaptured heterogeneity in advanced EHR hospitals could have weakened 
the ability to detect differences in groups. Third, medication errors were identified using 
ICD-9 codes consistent with medication errors and may not as sufficiently capture all 
medication errors as more thorough review of records. Studies reporting more medication 
errors at baseline have been associated with intervention study findings of greater 
reductions in medication errors (Nuckols et al., 2014). Fourth, comparisons between 
advanced EHR and all non-EHR, rather than solely focusing on hospitals without any 
EHR could have produced greater differences. However, such an approach would not 
have adequately measured specific differences in the stage of EHR, which was the focus 
of this study. Fifth, some studies have indicated that the mere presence or absence of an 
EHR may not affect medication error or adverse effects in general with other 
characteristics that are key to implementation such as physician buy-in and ease of use 
(Encinosa & Bae, 2013). Finally, this study did not focus on any particular patient group, 
and it is possible that differences may be observed among subgroups that are not 
detectable across all patient populations. 
Although the result of little to no difference between rates of medication error in 
advanced vs. non-advanced EHR hospitals differs from results of other studies, 
descriptive analyses of characteristics of medication errors in general reflect that of 
previous reports of healthcare utilization data. For example, a 2004 report of adverse 
events found an overall prevalence of adverse drug events of about 3.1 (somewhat similar 
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to the adjusted estimates of 4.0 and 3.9 reported in this study). Additionally, the 
distributions of medication error categories by age were similar. 
Additionally, the data used for our study are from 2009 and before the meaningful 
use incentives took effect, which may also partially explain our results. The investment 
from both the public and private sector increased significantly after 2009 to enhance the 
functionality of EHRs. Consequently, the current data may tell a different story as, in 
addition, these same hospitals also have more experience using EHR systems than they 
did six years ago.  
Technology alone will not solve the problem of medication errors in healthcare; 
there must be comprehensive approach to the problem that includes the EHRs not 
reliance on the EHR to solve the problem. Jha cites hyperbole around electronic health 
records, along with real progress toward implementation: “But the potential is not going 
to be realized unless those tools are really focused on improving patient safety. The tools 
themselves won't automatically do it” (McCann, 2014).  
Limitations 
The data from HIMSS Analytics are mostly self-reported, causing some concerns 
with the accuracy, but not significant enough concerns to affect the validity of this study.  
Some other limitations are low reporting of adverse events, complexity of EHR 
variability in configuration, low CPOE adoption rates and the lack of causation between 
advanced EHR use and medication errors. Another limitation of our study is the age of 
our data, which is from 2009 and is used because 2009 was the year HITECH was 
enacted as part of the American Reinvestment and Recovery Act (ARRA) passed by 
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Congress. This gives us a picture of the effects of using an advanced EHR before the 
Meaningful Use incentives took effect. Also, we can only show association, not 
causation, among our variables 
A follow up study with current data is highly recommended to see how the results 
will differ with all the technology and process enhancements since 2009, as hospitals are 
now required to attest to a significant number of new advance features within an EHR 
plus other meaningful use measures. It’s not acceptable anymore to limit CPOE or EHR 
use to one unit.   Also, early adopters also have a lot more experience in using EHRs 
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EHR Adoption Model 
 
Stage Descriptor 
Stage 0 No EHR applications installed 
Stage 1 EHR with ancillary services including a clinical data repository, 
pharmacy, laboratory, and radiology information systems 
Stage 2 Stage 1 plus EHR with nursing workflow including electronic 
nursing documentation and medication administration records 
Stage 3 (Advanced 
EHR) 
EHR with Stage 1 and 2 components, plus CPOE and clinical 
decision support 
 
(Kazley, 2014)  
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Table 2  
 
International Classification of Diseases, 9th Revision, Clinical Modification Adverse 
Drug Events Flag Code 
 
ADE Type Class ICD9 Flag Code 
Clinical side effects Drug psychoses 292.0–292.9 
Clinical side effects Dermatitis 692.3, 692.9, 693.0, 693.8, 693.9 




intoxications specific to 
newborn 
760.72, 760.74, 763.5, 779.4 
Clinical side effects Rash, spontaneous 
ecchymoses 
782.1, 782.7 
Poisonings By antibiotics and other 
antiinfectives  
960–961, E856–857 
Poisonings By hormones and synthetic 
substitutes  
962, E858.0 
Poisonings By primarily systemic 
agents 
963, E858.1 
Poisonings By agents primarily 
affecting blood constituents 
964, E858.2 
Poisonings By analgesics, antipyretics, 
antirheumatics 
965, E850 
Poisonings By anticonvulsant and anti-
Parkinsonian drugs 
966, E855.0 
Poisonings By sedatives and hypnotics 967, E851–852 
Poisonings By other central nervous 
system depressants, 
stimulants, anesthetics, 
nervous system agents 
968, E855.1–855.9 
Poisonings By psychotropic agents 969, E853–854 
Poisonings By other agents 969, E853–854 
Adverse effects Of antibiotics and other 
antiinfectives 
E930–931 
Adverse effects Of hormones and synthetic 
substitutes 
E932 
Adverse effects Of primarily systemic 
agents 
E933 
Adverse effects Of agents primarily 
affecting blood constituents 
E934 
Adverse effects Of analgesics, antipyretics, 
antirheumatics 
E935 
Adverse effects Of anticonvulsant and anti- E936 
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ADE Type Class ICD9 Flag Code 
Parkinsonian drugs 
Adverse effects Of sedatives and hypnotics E937 
Adverse effects Of other central nervous 
system depressants, 
stimulants, anesthetics, 
nervous system agents 
E938, E940–941 
Adverse effects Of psychotropic agents E939 
Adverse effects Of agents primarily 
affecting the cardiovascular 
system 
E942 
Adverse effects Of other drugs, biological, 




























Age in years 48.3 (27.9) 49.4 (27.7) 45.9 (28.0) <0.0001 
Risk mortality 1.60 (0.88) 1.62 (0.88) 1.57 (0.87) <0.0001 
Risk severity 1.97 (0.91) 1.95 (0.91) 1.97 (0.91) <0.0001 
     
Adverse drug events 67,724 (6.6) 48,772 (6.7) 18,952 (6.3) <0.0001 
Medicaid 215,441 (20.9) 149,105 (20.4)    66,338 (22.1)  <0.0001 
Medicare 380,804 (36.9) 281,521 (38.5) 99,283 (33.1)  
Private insurance 343,188 (33.3) 237,420 (32.5) 105,768 (35.2)  
Other ins/self pay/no 
charge 
91,350 (8.9) 62,332 (8.5)  29,018 (9.7)  
Neonatal/maternal admit 235,592 (22.8) 162,799 (22.3) 72,793 (24.2) <0.0001 
Transfer into hospital 56,766 (5.5) 35,497 (4.9) 21,269 (7.1) <0.0001 
Race/Ethnicity     
     White 591,032 (57.2) 433,788 (59.3) 157,244 (52.2) <0.0001 
     Black 117,404 (11.4) 76,097 (10.4) 41,307 (13.7)  
     Hispanic 124,379 (12.0) 90,275 (12.3) 34,104 (11.3)  
     Other/missing 200,086 (12.0) 131,452 (18.0) 68,634 (22.8)  
Teaching hospital 504,828 (48.9) 310,797 (42.5)  194,031 (64.4) <0.0001 
Urban hospital 930,479 (90.1) 639,567 (87.4) 290,912 (96.6) <0.0001 
Small hospital 116,715 (11.3)  93,943 (12.8) 22,772 (7.6) <0.0001 
Medium hospital 248,545 (24.1) 170,981 (23.4)  77,564 (25.7)   
Large hospital 667,645 (64.6) 466,692 (63.8) 200,953 (66.7)  
Northeastern United 
States 
281,526 (27.3) 166,609 (22.8) 114,917 (38.1) <0.0001 
Midwestern United States 133,327 (12.9) 72,746 (9.9) 60,581 (20.1)  
Western United States 295,064 (28.6) 22,9429 (31.4) 65,635 (21.8)  





Table 4  
Zero-Inflated Poisson Parameter Estimates  
 Poisson Binomial (Probability of zero medication errors) 
Variable Estimate 95% CI P Estimate 95% CI p 
Advanced EHRs 0.0095 -0.0052, 0.0242 0.2058 0.0045 0.0273, 0.0637 <0.0001 
Age -0.0101 -0.0105, -0.0096 <0.0001 -0.0008 -0.0013, -0.0002 0.0051 
Female  0.0784 0.0656, 0.0911 <0.0001 -0.0434 -0.0593, -0.0275 <0.0001 
Race       
     Black -0.5211 -0.5466, -0.4957 <0.0001 -0.3960 -0.4304, -0.3617 <0.0001 
     Hispanic -0.3660 -0.3930, -0.3390 <0.0001 0.0840 0.0521, 0.1160, <0.0001 
     Other/unknown -0.2649 -0.2870, -0.2427 <0.0001 -0.1527 -0.1803, -0.1250 <0.0001 
     White (ref) Ref      
Risk mortality -0.0059 -0.0164, 0.0047 0.2744 -0.1992 -0.2128, -0.1855 <0.0001 
Risk severity 0.0617 0.0502, 0.0732 <0.0001 -0.4464 -0.4603, -0.4325 <0.0001 
Neonatal or maternal admit -0.6434 -0.6886, -0.5982 <0.0001 1.4943 1.4482, 1.5404 <0.0001 
Teaching hospital 0.0871 0.0677, 0.1065 <0.001 0.1579 0.1336, 0.1822 <0.0001 
Hospital’s number of beds -0.0049 -0.0161, 0.0062 0.3841 0.0450 0.0311, 0.0589 <0.0001 
Urban vs. Rural location 0.1574 0.1272, 0.1876 <0.0001 0.1052 0.0672, 0.1432 <0.0001 
Insurance       
     Medicaid 0.0093 -0.0109, 0.0295 0.3669 -0.1367 -0.1610, -0.1124 <0.0001 
     Medicare 0.0217 0.0038, 0.0397 0.0178 0.0690 -0.0912, -0.0467 <0.0001 
     Other insurance/self-pay/no charge 0.0548 0.0315, 0.0780 <0.0001 -0.1392 -0.1671, -0.1112 <0.0001 
     Private Ref      
Geographic Region       
     Midwest 0.0999 0.0689, 0.1309 <0.001 -0.1725 -0.2114, -0.1336 <0.0001 
     Northeast -0.0197 -0.0466, 0.0072 0.1515 0.0760 0.0428, 0.1093 <0.0001 
     South -0.0763 -0.0942, -0.0584 <0.0001 -0.0178 -0.0400, 0.0044 0.1157 
     West Ref      
Transferred into hospital 0.0399 0.0215, 0.0582 <0.0001 <0.0001 0.1199, 0.1666 <0.0001 
Case Mix -0.0138 -0.0169, -0.0107 <0.0001 <0.0001 0.0735, 0.0817 <0.0001 








 Binomial (Probability of medication errors) 
Variable Estimate 95% CI P 
Advanced EHRs -0.0291 -0.0378, -0.0205 <0.0001 
Age -0.0077 -0.0079, -0.0075 <0.0001 
Female  0.1081 0.1006, 0.1155 <0.0001 
Race    
     Black -0.1545 -0.1669, -0.1422 <0.0001 
     Hispanic -0.3871 0.4015, 0.3726 <0.0001 
     Other/unknown -0.0992 -0.1110, -0.0874 <0.001 
     White (ref) Ref   
Risk mortality 0.1368 0.1306, 0.1429 <0.0001 
Risk severity 0.4214 0.4150, 0.4278 <0.0001 
Neonatal or maternal admit -1.9713 -1.9919, -.1.9506 <0.0001 
Teaching hospital -0.0494 -0.0606, -0.0382 <0.0001 
Hospital’s number of beds -0.0366 -0.0428, -0.0303 <0.0001 
Urban vs. Rural location 0.0590 0.0424, 0.0757 <0.0001 
Insurance    
     Medicaid 0.1238 0.1116, 0.1360 <0.0001 
     Medicare 0.0720 0.0614, 0,0826 <0.0001 
     Other insurance/self-pay/no charge 0.1527 0.1386, 0.1668 <0.0001 
     Private Ref   
Geographic Region    
     Midwest 0.3385 0.2108, 0.2462 <0.0001 
     Northeast -0.0828 -0.0982, -0.0675 <0.0001 
     South -0.0515 -0.0619, -0.0411 <0.0001 
     West Ref   
Transferred into hospital -0.0863 -0.0969, -0.0757 <0.0001 
Case Mix -0.0785 -0.0810, -0.0761 <0.0001 
Propensity strata -0;.0257 -0.0331, -0.0i83 <0.0001 
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Table 6  
 
Base Estimate Propensity Strata and Matched Sample Proportions of Medication Errors 
Among Hospitals with and without Advanced EHR (Logistic Regression Model) 
 
 Base Estimate Propensity 
Strata (n=1,032,905) 
Base Estimate Propensity 
Matched Sample  
(n=61,390) 
Advance EHR 0.039 0.037 
No Advanced EHR 0.040 0.036 







Table 7  
 




Ensure that leaders establish and sustain a safety culture. 
 
2. Create centralized and coordinated oversight of patient safety. 
 
3. Create a common set of metrics that reflect meaningful outcomes. 
 
4. Increase funding for research in patient safety and implementation science. 
 
5. Address safety across the entire care continuum. 
 
6. Support the health care workforce. 
 
7. Partner with patients and families for the safest care. 
 
8. Ensure that technology is safe and optimized to improve patient safety. 
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A review of the literature revealed the need for further analysis of the impact of 
advanced electronic health record (EHR) use on medication error rates within US 
hospitals. 
Objective 
To evaluate the effects of advanced electronic health record use on the medication 
error rates in an inpatient setting. 
Study Design 
A retrospective cross-sectional patient level analysis using the combined 2009 
data from the National Inpatient Sample (NIS), HIMSS, and AHA datasets was 
conducted to study the relationship between advanced electronic health records use and 
medication error rates. 
Findings  
A random sample of 1,032,905 patient cases was selected. A total of 301,289 
(29.2%) patient cases originated from hospitals with an advanced EHR. A total of 550 
hospitals were included in the analysis, with 104 (18.9%) reporting use of advanced 
EHR. Compared to patient cases from hospitals without advanced EHR, those with 
advanced EHR had a lower proportion of medication errors (6.7% vs. 6.3%, p < 0.0001). 
The most important finding in this study is that there was only a small difference in the 
assumed direction to begin with, but it remained when using the propensity score 
stratification although the association was no longer statistically significant when using 




While use of advanced EHRs has great potential for improving a variety of health 
and safety matters in the hospital, it is possible that its current implementation has not 
evolved enough to have an effect. Technology alone will not solve the problem, but it can 
be a part of the solution. We must establish a total systems approach to problem of 
patient safety where technology is part of the solution. 
 
Keywords: CPOE: Computerized provider order entry (CPOE), clinical decision 
support (CDS), adverse drug events (ADE), medication error (ME), advanced 
electronic health record (EHR), The American Reinvestment & Recovery Act 




Advanced Electronic Health Records (EHR) and Their Impact on Medication 
Errors 
Introduction 
Patient safety has emerged as a central measure of quality in today’s healthcare 
environment that has far-reaching impact on various aspects in the continuum of care. 
The practice of patient safety has been defined as those practices that reduce the risk of 
adverse events related to exposure to medical care across a range of diagnoses or 
conditions (Shojania et al., 2001). The Institute of Medicine (IOM) defines patient safety 
as the prevention of harm to patients (Berkowitz et al., 2012) and places it under the 
overarching umbrella of quality measures in healthcare (Kohn et al., 2000). Emphasis is 
placed on the system of care delivery that (1) prevents errors, (2) learns from the errors 
that do occur, and (3) is built on a culture of safety that involves health care 
professionals, organizations, and patients (Aspden, 2004). The Agency for Healthcare 
Research and Quality's (AHRQ) Patient Safety Network website expands upon the 
definition of prevention of harm, describing it as freedom from accidental or preventable 
injuries produced by medical care (AHRQ, 2007).  
Background 
 A number of studies have shown that patient safety is of great concern to the 
entire healthcare community, especially to patients. Covell & Ritchie (2009) concluded 
that even though healthcare providers have ethical and professional obligations to 
disclose adverse events, medication errors continue to be underreported. Consequently, 
little is known about the types of medication errors that are not reported. Shojania et al. 
(2001) found that many patient safety practices drawn primarily from nonmedical fields 
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(e.g., use of simulators, bar coding, computerized physician order entry, crew resource 
management) deserve additional research to illuminate their value in the health care 
environment. Varkey & Bisping (2007) found that interventions resulted in a decrease in 
prescription medication errors significantly. 
In our review, healthcare information technology is shown to play a significant 
role in the delivery of care, and a number of studies show a positive correlation between 
healthcare information technology and improvement in the quality of care. Spina et al. 
found that 90 percent of all providers felt that the VA’s electronic prescribing system, 
including its order check, improved prescribing safety to some degree. CPOE with CDS 
were shown to improve patient safety, according to Kurshal et al. (2006). More evidence 
was offered by Dexter et al. (2001) that CPOE can also improve compliance with 
provider guidelines, as well as the efficiency of hospital workflows. In their 2004 study, 
Handler et al. suggest that CPOE and decision support systems (DSS) can reduce certain 
types of errors, and Birkmeyer (2004) also concluded that CPOEs have a positive 
correlation to the reduction of medication errors.  
Studies also revealed that although the level of EHR adoption has increased, the 
true impact of Meaningful Use is still to be determined. In 2010 Jha et al. found that EHR 
adoption had increased to about 75 percent since 2008. Charles et al. (2014) show that the 
number of EHRs with less advance features has declined marginally, while the number of 
systems with more advance functionality has increased significantly. In a related study, 
Diana et al. (2014) found that 38 percent of eligible hospitals had achieved Meaningful 
Use incentive thresholds by the end of 2012. A number of studies were reviewed that 
point to an increase in EHR adoption, but few or none showing the true impact of the 
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Meaningful Use incentives. That may come in time as systems mature and data is 
collected on these newly implemented features. 
Overall, the review of the available literature did shine a light on the importance 
of patient safety practices and shows the impact of various parts of an EHR on patient 
safety and quality, but nothing significant relating to how advanced EHRs are impacting 
medication errors. Our study will attempt to fill this void and add to the knowledge base 
in the area of patient safety. IOM conducted a landmark study in 1999 on medical errors 
and found that medical errors lead to the deaths of between 44,000 and 98,000 people in 
US hospitals each year (JHITA, 2000). The Journal of the American Medical Association 
gives a more conservative estimate and states that between 5,000 and 15,000 of those 
deaths were preventable (Gillespie, 2002). One type of medical error is an adverse drug 
event (ADE), which are a subset of those injuries associated with errors that occur during 
the ordering, administering, dispensing, and monitoring of drugs. ADEs increase 
morbidity, mortality and health care costs (Wolfstadt et al., 2008).  
In addition to their impact on patient mortality, ADEs exact other significant 
costs. They have been estimated to result in higher costs due to additional care 
necessitated by the errors, lost income and household productivity, and disability of 
between $17 billion and $29 billion per year in hospitals nationwide (JHITA, 2000). The 
impact of medication errors is also felt when patients lose trust in the health care system 
and when both patients and health professionals experience reduced satisfaction. Patients 
who experience a long hospital stay or disability as a result of errors experience physical 
and psychological discomfort. Health professionals pay with loss of morale and 
frustration at not being able to provide the best care possible. Society bears the costs of 
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errors as well, in terms of lost worker productivity, reduced school attendance by 
children, and poorer population health (Kohn et al., 2000).  
A number of factors contribute to medication errors. One of the most challenging 
but preventable factors is the decentralized and fragmented nature of the healthcare 
delivery system. When patients see multiple providers in different settings, none of whom 
have access to complete information, it becomes easier for errors to occur (Kohn et al., 
2000).  
Historically, most third-party purchasers of healthcare provided little financial 
incentive for health care organizations and providers to improve safety and quality (Kohn 
et al., 2000). Pay for Performance is changing the way Medicare pays for hospital care by 
rewarding hospitals for delivering services of higher quality and higher value. The 
program is an umbrella term for initiatives aimed at improving the quality, efficiency, 
and overall value of health care. In some Pay for Performance models, payers consider 
information technology critical to improving the coordination, quality, and efficiency of 
care. In such a measure, payers might reward organizations for the use of an EHR to 
order prescriptions for their patients, a process that can both lower costs and improve 
quality by reducing medication errors (Cromwell et al., 2011). 
Many patient safety practices that are tied to information technology, such as 
simulators, bar coding, computerized physician order entries, and crew resource 
management, which have been considered as possible strategies to avoid patient safety 
errors and improve healthcare processes. Although not all adverse events in healthcare 
are preventable, IOM concluded that many could be avoided through better professional 
practices, more effective teamwork, and new technology (Berkowitz et al., 2012). EHRs 
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that use computerized physician order entry (CPOE) with clinical decision support (CDS) 
have been promoted as an effective strategy to prevent the development of a drug injury 
defined as an adverse drug event (ADE) (Wolfstadt et al., 2008). CDS is a technology 
that provides clinicians with real-time feedback about a wide range of diagnostic and 
treatment-related information as they are entering electronic orders. By running 
electronic rules in the background, decision support can check for a variety of potential 
errors such as drug interactions, patient allergies to prescribed medications, medication 
contraindications, and renal- and weight-based dosing. For a number of years, 
organizations such as the Institute of Medicine and Leapfrog have been calling for 
implementation of advanced EHRs, and CPOE in particular (Milstein et al., 2000). 
The pace of change has greatly accelerated since the passage of the Health 
Information Technology for Economic and Clinical Health Act (HITECH) which is part 
of the American Reinvestment & Recovery Act (ARRA) of 2009. This is an effort to 
transform healthcare delivery through widespread adoption and use of EHR technology. 
Meaningful Use is an incentive program authored by the Centers for Medicare & 
Medicaid Services (CMS) that provides eligible hospitals and professionals with financial 
incentives to implement EHR systems and demonstrate “meaningful use” of certified 
systems.   
HITECH proposes the meaningful use of interoperable EHRs throughout the 
health care delivery system as a critical national goal. The concept of meaningful use 
rests on five pillars of health outcomes policy priorities, namely: (1) improving quality, 
safety, efficiency, and reducing health disparities; (2) engaging patients and families in 
their own healthcare; (3) improving care coordination; (4) improving population and 
56 
 
public health; and (5) ensuring adequate privacy and security protection for personal 
health information (CMS.gov).  
By providing incentives to individual providers for using EHR systems in specific 
ways, CMS has motivated a fragmented customer base to behave more like a single 
customer with coherent demands. In effect, CMS, as a behind-the-scenes customer, is 
driving standardization and the resulting economies of scale and scope in the EHR field 
in the same way that large industry players have been able to standardize and draw value 
from IT use in banking, retail merchandising, airlines, food services, and other sectors of 
the economy. Understanding that markets are often slow to respond to customer demand, 
and that EHR purchasers have limited ability to evaluate the quality of EHR vendor 
products prior to purchase, HITECH also created federal certification of EHR products. 
This certification gives a degree of assurance to providers and CMS about the quality of 
EHR products they purchase (HealthIT.gov, 2016). 
The Meaningful Use incentive program was established with three phases: Stage 
1, Data Capture and Sharing; Stage 2, Advanced Clinical Processes; and Stage 3, 
Improved Outcomes. Stage 1 of the Meaningful Use program focuses primarily on 
promoting consistency of documentation in terms of what data should be captured 
(content) and how it should be presented (structure). It does not address in detail how 
data should be recorded (vocabulary) (HealthIT.gov, 2016). Stage 1 also links 
documentation requirements with measurement and decision support requirements to 
ensure that the data being captured are more than just a description of observations, 
diagnoses, and treatments for future reference; clinicians now had the systems and the 
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motivation to document in ways that would allow EHR systems to be tools for enhanced 
decision-making (see Table 1).  
In terms of interoperability of systems, Stage 1 focuses on promoting inter-
organization electronic transactions that were already gaining acceptance in the market, 
such as e-prescribing, lab results delivery, and public health reporting. It also laid the 
foundation for new types of transactions, specifically EHR-to-EHR transactions, by 
requiring that systems be able to generate electronic record extracts that can be read by 
other systems. The ability to electronically send, receive, and incorporate such extracts 
from other EHR systems was left for more advanced stages. 
Stage 2 Meaningful Use requires hospitals and health care providers to meet more 
advanced requirements to qualify for incentives during this stage, and specifies what 
criteria electronic health records must meet to achieve certification. Specific to Stage 2, 
the capability to submit electronic data about immunizations is in the core set of criteria 
for eligible professionals (EPs), as are the capability to submit electronic data for 
immunizations, reportable laboratory results, and syndromic surveillance. In addition, 
two new public health objectives for EPs have been added to the menu set, requiring the 
capability to 1) identify and report cancer cases to a cancer registry and 2) identify and 
report non-cancer cases to specialized registries. 
Stage 2 further refines the notion of system-neutral records by taking EHR-to-
EHR interoperability further and requiring not just common structures (consolidated 
clinical document architecture (CDA)) and common content (problems, labs, 
medications, etc.), but use of specific vocabularies as well, such as SNOMED CT, 
LOINC, and RxNORM, to enable cross-system understanding of clinical information 
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from one organization to another. And while Stage 1 simply requires that systems be able 
to generate standardized clinical documents, Stage 2 requires that they be able to 
transport clinical information from one system to another. 
Stage 3 rules were announced in October 2015, making significant changes 
intended to ease the reporting burden on all providers, support health information 
exchange, and improve patient outcomes. One important change is a shift in focus so that 
health IT becomes a tool for care improvement, not an end in itself. 
While each stage of Meaningful Use has sent ripples of change across the EHR 
landscape in terms of functions and capabilities, each stage has also engendered evolution 
in the very definition of an EHR. While Meaningful Use is not yet complete, it is not too 
early to assess how it is already shaping the field. Setting common functional 
requirements for EHRs and incentives for users to take advantage of those functions, the 
Meaningful Use program has imposed a degree of coordination on healthcare that the 
fragmentation of the industry has prevented up until now. Meaningful Use can go only so 
far, however, as it is not robust enough to change larger and deeper trends in the industry 
that are driving business arrangements and revenue models.  
Meaningful Use has certainly been successful in creating a common floor of 
capability across vendors’ systems, which has inalterably shaped the EHR industry. It has 
also had a profound impact on the widespread adoption and use of EHR systems in 
hospitals and physician practice. Vendors have yet to reach plug-and-play capability with 
EHR systems, however, and it is highly unlikely that Meaningful Use will have enough 




There has been little research on the overall effectiveness of advanced EHRs on 
medication errors in an inpatient setting, using the HIMSS Analytics participating 
hospitals as the sample population. Various studies have attempted to show the value of 
various aspects of technology on patient care, but no comprehensive research had 
conducted to evaluate the relationship between advanced EHR use and medication errors 
among US hospitals. This study has sought to describe the relationship between advanced 
EHR use and medication errors among US hospitals participating in a survey by HIMSS, 
a global, cause-based, not-for-profit organization focused on better health through 
information technology (IT). The research hypothesis of this study was that hospitals 
with advanced EHRs have lower rates of medication errors compared to hospitals without 
advanced EHRs. 
Methods 
Sample and Databases  
The sample size was a 20% random sample of patients in the HIMSS Analytics 
data 2009 that includes a broad canvassing of acute care hospitals, which are also in the 
NIS and AHA datasets. The patients in our sample were grouped by stage of use of EHR, 
a model previously used by Kazley (2014), based on individual application reported to be 
in use by these hospitals in our sample.  
Study Design 
We conducted a retrospective, cross-sectional patient level study of the data from 
HIMSS Analytics for each hospital’s advanced EHR adoption scores, AHA datasets, and 
the NIS data for the medication error rates. We analyzed the data to determine to what 
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extent medication errors are affected by advance EHR usage. We identified the 
independent variable as advanced EHR usage, and its effects on medication error rates 
were measured.  
Specification of variables. In this study, the independent variable was advanced 
(Stage 3) EHR usage. The EHR usage level was classified into four stages based on 
various components of an EHR reported to be in use at the time of reporting (see Table 
1). These measures were grouped into categories to measure the level EHR functionality 
of each hospital in its EHR journey. This was appropriate for our study in that it allowed 
us to measure the effects on medication error rates for each hospital as the hospital adopts 
additional components of an EHR. The categories we used are Stage 0 (no EHR 
applications installed), Stage 1 (EHR with ancillary services including a clinical data 
repository, pharmacy, laboratory, and radiology information systems), Stage 2 (Stage 1 
plus EHR with nursing workflow including electronic nursing documentation and 
medication administration records), and Stage 3 (EHR with Stage 1 and 2 components, 
plus CPOE and clinical decision support). A hospital with Stage 3 EHR reported 
successful implementation all of all Stage 1 and Stage 2 applications plus CPOE and 
CDS. Teufel et al. (2012) point out that many of the functions present in advanced Stage 
3 would be considered minimal functions required to meet Meaningful Use Stage 1 
objectives. Since Stage 3 consists of more advanced automated features, we expected 
Stage 3 hospitals to possess enhance capabilities to handle the demands of providing high 
quality care, which in turn affects the patient safety capabilities of those hospitals. 
 The dependent variable in this study was the number of medication errors found 
at participating hospitals. The results were compared to a control group of hospitals 
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without advanced EHRs that are in Stages 0, 1, and 2 of our EHR classification model. 
The control group for non-advanced EHR represented EHRs without CPOE of CDS. We 
tested whether the experimental treatment/condition (advanced EHR) is associated with 
fewer medication errors, and whether there is sufficient evidence to support the claim that 
it is. We controlled for several hospital level variables: teaching status, urban location, 
bed count, and geographical region. Given that the patient was the unit of analysis, we 
also controlled for patient level variables: patient age, gender, race, private insurance 
coverage, Medicare and Medicaid coverage, and whether the patient arrived as a transfer. 
We also controlled for potential selection bias of advanced EHR use in hospitals and 
potential differences in patient demographics, severity of errors, and hospital case mix 
through the use of a propensity score stratification model. To calculate the propensity 
score, a logistic regression analysis was performed to estimate the likelihood of each 
patient being seen in a hospital with an advanced EHR (see Table 5). Once calculated, the 
propensity score variable was added to the multivariate model to control for potential 
selection bias. Use of a propensity score approach can remove upward of 95% of bias 
from estimates (Teufel et al., 2012). 
Data collection. We used secondary data from the HIMSS Analytics 2009 
database for hospitals in combination with the National Inpatient Sample (NIS) 2009 data 
for patient identifiers for medication errors and AHA datasets. The HIMSS Analytics 
data were combined with demographic data from NIS to measure the impact of advanced 
EHR use and medication error rates. NIS is a family of health care databases and related 
software products developed through a federal-state-industry partnership and sponsored 
by the Agency for Healthcare Research and Quality (AHRQ). NIS databases bring 
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together the data collection efforts of state data organizations, hospital associations, 
private data organizations, and the federal government to create a national information 
resource of encounter-level health care data, the National Inpatient Sample (NIS). NIS 
includes the largest collection of longitudinal hospital care data in the United States, with 
all-payer, encounter-level information beginning in 1988. These databases enable 
research on a broad range of health policy issues, including cost and quality of health 
services, medical practice patterns, access to health care programs, and outcomes of 
treatments at the national, state, and local market levels (AHRQ.gov). The AHA database 
is based on an annual survey of US hospitals that collects data about hospital 
characteristics and was used for control variables.  
The International Classification of Diseases, 9
th
 Revision, Clinical Modification 
(ICD-9-CM) codes, assigned to virtually all inpatient discharges, provides a readily 
available surveillance system capable of detecting an ADE. The most frequently assigned 
ICD-9-CM codes are diagnosis codes, external cause of injury codes (E-codes), and 
procedure codes. In the case of an adverse drug event (ADE), a diagnosis code is used to 
indicate the patient’s general diagnosis (e.g., 693.0, dermatitis due to drugs and 
medicines taken internally), while the E-code indicates the drug class thought to be 
responsible for these symptoms (e.g., E933.1, antineoplastic and immunosuppressive 
drugs causing adverse effects in therapeutic use) (see Table 2).  
To determine the medication error rates, we employed the model used previously 
by Hougland et al. in their 2006 study. They conducted a structured chart review and 
abstraction to identify all Adverse Events and whether a flagged ICD-9-CM code 
represented an Adverse Event. Adverse Event codes were grouped into six categories to 
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facilitate analysis: adverse drug events, surgical adverse events, misadventures, 
infections, device events, and other adverse events. Our study focused on the Adverse 
Drug Events (ADE) category to measure medication errors. Hougland et al. identified 
416 ICD-9-CM codes representing ADEs (flagged ADE codes) which are represented in 
Table 2. The Hougland study concluded that flagged ADE codes have a positive 
predictive value of 25% for inpatient ADEs, and even though the flagged ADE codes 
model is imperfect, it does provide an immediately available ADE surveillance system. 
For the purposes of identifying medication errors, we measured ADE flagged 
codes associated with clinical side effects, poisoning, and adverse effects (see Table 2). 
The poisoning codes for medication errors are used relatively infrequently; however, the 
poisoning codes were much more likely to detect ADEs causing admission than those 
ADEs that occurred in the hospital. Adverse effects codes are used more commonly than 
the poisoning codes, which are the adverse effect codes that denote adverse drug 
reactions (Hougland et al., 2008).  
Data Analysis 
The number of medication errors was determined for each admission by adding 
the number of ICD-9 and the number of E-codes corresponding to adverse drug effects 
(as specified in previous studies) for each patient case. (Hougland et al., 2006) 
Medication errors were categorized as clinical side effects, poisonings, and other adverse 
effects due to various agents according to methods outlined by Hougland (2006).  
Overall means (continuous variables) and proportions (categorical variables) were 
computed. Unadjusted analyses of patient and hospital-level characteristics were assessed 
by advance EHR status using t-tests (continuous variables) and chi-squared tests 
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(categorical variables). Among those with at least one medication error, the types of 
errors were compared descriptively by age, race, insurance, hospital’s number of beds, 
and hospital region. 
The generalized linear models predicting the number of medication errors and the 
probability of an admission originating from hospital with an advanced electronic health 
records (EHRs) (i.e. propensity model) were both controlled for the following patient 
level variables: patient age, gender, race, All Patient Diagnosis Related Groups 
(APDRGs) mortality and severity, insurance type (Medicaid, Medicare, private, other), 
neonatal or maternal status, Diagnosis Related Group (DRG) case mix group, and 
whether the patient arrived as a transfer. The following hospital-level variables were also 
controlled for in each model: teaching status, hospital location (urban vs. rural), 
hospital’s number of beds, and geographical region. Models were also weighted by 
hospital. 
A generalized linear model (binomial or logistic regression) was used to assess 
whether the proportion of patient cases reporting at least one medication error differs 
from hospitals with and without advanced EHRs. Generalized linear modeling was used 
assess whether the number of medication errors differs between hospital with and without 
advanced EHRs. Because the distribution of the number of medication errors contained 
high prevalence of zeros, a zero-inflated Poisson model (rather than the usual Poisson 
model) was used to model the total number of medication errors (see Table 4). Dependent 
variables following a Poisson distribution are expected to have a mean equal to the 
variance. In cases of excessive zero counts, this condition is not satisfied, and over-
dispersion results. Over-dispersion can lead to an overestimate of standard errors, which 
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affects the ability to determine statistical significance of covariates within the model. 
Furthermore, the underlying distribution is often a mixture of distributions including both 
a distribution predicting zeros (binomial) and a distribution predicting counts (Poisson). It 
has been demonstrated that the use of zero-inflated Poisson models can correct the 
problem of over-dispersion (Lambert, 1992).  
Two methods were used to control for selection bias. First, potential selection bias 
of advanced EHR use in hospitals and potential differences in patient demographics, case 
severity, and hospital case mix were controlled by using propensity score stratification 
(see Table 6). The propensity score was generated by modeling advanced EHR use by 
fitting a logistic regression model and estimating the probability of advanced EHR for 
each patient case. These probabilities were stratified into quintiles, and the stratified 
variable was added to the final model associating advanced EHR with the outcomes of 
interest. Use of a propensity score approach has been shown to remove upward of 95% of 
bias from estimates. (Tuefel, 2012). Data were analyzed using SAS version 9.3, and the 
model was run using the GENMOD procedure (SAS Institute Inc., 2002-2010) (see Table 
6). 
Second, potential selection bias due to case mix, patient and hospital 
characteristics were examined using propensity score matching techniques. A five 
percent random sample of the data was developed using propensity score matching based 
on the nearest neighbor-matching greedy algorithm approach. The sample was limited to 
30,695 randomly selected observations from each group (hospitals with and without 




A 20 percent simple random sample of the combined 2009 NIS and NIMMSS 
datasets was utilized for this analysis. A total of 1,032,905 patient cases were selected. A 
total of 301,289 (29.2%) patient cases originated from hospitals with an advanced EHR. 
A total of 550 hospitals were included in the analysis, with 104 (18.9%) reporting use of 
advanced EHR. The total number of medication errors per patient case ranged 0-11. The 
total number of admissions with at least one medication error was 67,724 (6.6%), and the 
average number of medication errors per patient case was 0.08 (SD = 0.35) overall, 
which is reflective of the large number of patient cases reporting zero medication errors. 
The average number of medication errors among patient cases with at least one 
medication error was 1.27 (SD = 0.61), with an average of 1.27 (SD = 0.59) among 
admissions with advanced EHR, and 1.27 (SD = 0.62) among those without an advanced 
EHR, p < 0.0001.  
Table 3 displays unadjusted differences in patient and hospital characteristics. All 
differences were statistically significant. The majority of covariate differences were 
small. Compared to patient cases from hospitals without advanced EHR, those with 
advanced EHR included a lower proportion of medication errors (6.7% vs. 6.3%, p < 
0.0001), were slightly younger in age, had a higher proportion of teaching hospitals and 
hospitals in urban locations. Other differences are displayed in Table 3. 
Additional unadjusted descriptive analyses of the subgroup of patient cases with 
medication errors indicated that the majority of reported medication errors were adverse 
drug effects, while the least reported was poisonings as categorized by Hougland et al. in 
their 2006 study. Adverse drug effects were highest among the oldest age group, while 
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poisonings were highest among the 18-44 year olds (see Table 2). The proportion of 
patient cases reporting clinical side effects was similar among the adult age groups. 
Among all patient cases with medication errors, White was the predominant 
race/ethnicity represented, and the most prevalent payer/insurance was Medicare, 
reflecting the distribution of the patient population. Similarly, the majority of medication 
errors were among the larger sized hospitals. The largest proportion of patient cases 
reporting medication errors were from the South (31.6%), however, the rates by 
geographical region were similar for each medication error category (see Table 3).  
Results of the zero-inflated Poisson models revealed that advanced EHR was 
positively associated with medication error, β = 0.0455 (p < 0.001), indicating that 
admissions with advanced EHRs were five percent more likely to have zero medication 
errors (OR = 1.047, 95% CI = 1.028-1.066) (see Table 4). No statistically significant 
association between the number of advanced EHRs and medication errors and was 
detected from the Poisson portion of the regression model, β = 0.0095 (p = 0.2058). 
Variables associated with both presence of medication error and an increased number of 
medication errors, included gender, race, risk severity, neonatal or maternal admission 
status, teaching hospital designation, urban location, geographical region of hospital, case 
mix, and propensity strata. Age was associated with a greater number of medication 
errors than were risk mortality, hospital’s number of beds, and insurance, which were 
each associated with at least one medication error. 
Although the two-part model (zero-inflated Poisson) used to assess the association 
between advanced EHR and number of medication errors included a model for assessing 
the presence or absence of medication error, a second model was used to assess the 
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second objective (to determine whether the proportion of medication errors differs in 
hospitals that do and do not use advanced EHRs). The remaining analyses focused on the 
logistic regression model (see Table 5) because (1) statistically significant association 
between number of medication errors and advance EHR use were detected; (2) no 
statistically significant association between number of medication errors and advanced 
EHR use were detected; and (3) the high proportion of zero medication errors per patient 
case considerably lowers the overall average below 1, making the mean values 
uninformative, indicating that the more valuable indicator is presence of medication error 
alone. Controlling for propensity strata, patient and hospital characteristics in the 
multivariable logistic regression model, the proportion of medication errors among 
hospitals without advanced EHRs was 4.0%, while the proportion of medication errors 
among hospitals with advanced EHRs was 3.9% (p < 0.0001) (see Table 4). Results from 
both the zero-inflated Poisson and the logistic regression models were controlled for 
propensity strata.  
Use of propensity score matching in the sensitivity analyses reduced the 
heterogeneity in the advanced EHR and non-advanced EHR groups as evidenced by the 
decrease in absolute standardized differences between covariates in the original dataset 
and the matched sample (Figure 1). Using the propensity matched sample, a slightly 
higher proportion of medication errors was detected among the advanced EHR group; 
however, this association was no longer statistically significant (3.7% vs. 3.6%, p = 
0.3958). This indicates that the small statistically significant difference revealed in prior 
analyses may have been due to selection bias (see Table 6). 
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The most important finding in this study is that there was only a small difference 
in the assumed direction to begin with, but it remained when using the propensity score 
stratification even though the association was no longer statistically significant when 
using the matched sample. This is likely due first to the small prevalence of medication 
errors overall and second, to the early stages implementation of advanced EHRs, as our 
data set is from 2009.  
Discussion 
The most important finding in this study is that there was only a small difference 
in the assumed direction to begin with, but it remained when using the propensity score 
stratification although the association was no longer statistically significant when using 
the matched sample. This is likely due first to the small prevalence of medication errors 
overall and second, to the early stages implementation of advanced EHRs, as our data set 
is from 2009.  
Initial analyses provided weak evidence that advanced EHR could potentially 
reduce medication error; however, sensitivity analyses indicated that this small difference 
may have been due to bias. Nearly identical estimates for the average number of 
medication errors and proportions of medication error in each group in dataset of this 
large size further indicate no difference in medication error among patient cases with and 
without advanced EHR. Additional analyses of the subgroup of patients with at least one 
medical error did not reveal differences in the average number medication errors among 
advanced and non-advanced EHR hospitals.  
While this analysis was strengthened by its use of sensitivity analyses to control 
selection bias, there are limitations. First, the data are cross-sectional, and at best only 
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provide weak evidence of an association between hospitals with and without advanced 
EHR and medication error with any implication of a cause and effect relationship. 
Second, data were collected in 2009, which represented a time of EHR uptake among 
hospitals. Thus, it is possible that even hospitals reporting advanced EHR may not have 
fully or properly implemented all elements that could have had an effect on medication 
errors. This uncaptured heterogeneity in advanced EHR hospitals could have weakened 
the ability to detect differences in groups. Third, medication errors were identified using 
ICD-9 codes consistent with medication errors and may not as sufficiently capture all 
medication errors as a more thorough review of records. Studies reporting more 
medication errors at baseline have been associated with intervention study findings of 
greater reductions in medication errors (Nuckols et al., 2014). Fourth, comparisons 
between advanced EHR and all non-EHR, rather than solely focusing on hospitals 
without any EHR could have produced greater differences. However, such an approach 
would not have adequately measured specific differences in the stage of EHR, which was 
the focus of this study. Fifth, some studies have indicated that the mere presence or 
absence of an EHR may not affect medication error or adverse effects in general with 
other characteristics that are key to implementation such as physician buy-in and ease of 
use (Encinosa & Bae, 2013). Finally, this study did not focus on any particular patient 
group, and it is possible that differences may be observed among subgroups that are not 
detectable across all patient populations. 
Although the result of little to no difference between rates of medication error in 
advanced vs. non-advanced EHR hospitals differs from results of other studies, 
descriptive analyses of characteristics of medication errors in general reflect that of 
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previous reports of healthcare utilization data. For example, a 2004 report of adverse 
events found an overall prevalence of adverse drug events of about 3.1 (somewhat similar 
to the adjusted estimates of 4.0 and 3.9 reported in this study). Additionally, the 
distributions of medication error categories by age were similar. 
Additionally, the data used for our study are from 2009 and before the meaningful 
use incentives took effect, which may also partially explain our results. The investment 
from both the public and private sector increased significantly after 2009 to enhance the 
functionality of EHRs, so the current data may tell a different story.  
Technology alone will not solve the problem of medication errors in healthcare; 
there must be comprehensive approach to the problem that includes the EHRs not 
reliance on the EHR to solve the problem. Jha cites hyperbole around electronic health 
records, along with real progress toward implementation: “But the potential is not going 
to be realized unless those tools are really focused on improving patient safety. The tools 
themselves won't automatically do it” (McCann, 2014)  
Limitations 
The data from HIMSS Analytics are mostly self-reported, causing some concerns 
with the accuracy, but not significant enough concerns to affect the validity of this study.  
Some other limitations are low reporting of adverse events, complexity of EHR 
variability in configuration, low CPOE adoption rates and the lack of causation between 
advanced EHR use and medication errors. Another limitation of our study is the age of 
our data, which is from 2009 and is used because 2009 was the year HITECH was 
enacted as part of the American Reinvestment and Recovery Act (ARRA) passed by 
Congress. This gives us a picture of the effects of using an advanced EHR before the 
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Meaningful Use incentives took effect. Also, we can only show association, not 
causation, among our variables. A follow-up study with current data is highly 
recommended to see how the results will differ with all the technology and process 
enhancements since 2009, as hospitals are now required to attest to a significant number 
of new advance features within an EHR plus other meaningful use measures. It is not 
acceptable anymore to limit CPOE or EHR use to one unit.   Also, early adopters also 
have a lot more experience in using EHRs which should reveal much more utility across 
the board. 
Conclusion 
Although technology can be used a tool as part of the solution, it is not the 
solution to the issues surrounding patient safety. For us to see a significant reduction in 
the medical errors, we must establish a total systems approach to the problem, where 
technology is only part of the solution. In early 2015, The National Patient Safety 
Foundation (NPSF) assembled a group of industry experts to assentation the current state 
of patient safety and they concluded in their final report that a total systems approach is 
needed to address the problem. In a final report entitled Free From Harm- Accelerating 
Patient Safety Improvements Fifteen years after to Err is Human, the panel provided eight 
recommendations for achieving total patient safety (see Table 7). The leading 
recommendation is to ensure that leaders establish and sustain a culture of safety; 
technology was included as the Number 8 recommendation. If we are to make advances 
in this area, this is the playbook that should be followed to establish total systems 








Table 1. EHR Adoption Model 
 
Stage Descriptor 
Stage 0 No EHR applications installed 
Stage 1 EHR with ancillary services including a clinical data repository, 
pharmacy, laboratory, and radiology information systems 
Stage 2 Stage 1 plus EHR with nursing workflow including electronic 
nursing documentation and medication administration records 
Stage 3 (Advanced 
EHR) 






Table 2. International Classification of Diseases, 9th Revision, Clinical Modification 
Adverse Drug Events Flag Code 
 
ADE Type Class ICD9 Flag Code 
Clinical side effects Drug psychoses 292.0–292.9 
Clinical side effects Dermatitis 692.3, 692.9, 693.0, 693.8, 
693.9 
Clinical side effects Maternal causes of perinatal 
morbidity/mortality, drug 
reactions and 
intoxications specific to 
newborn 
760.72, 760.74, 763.5, 779.4 
Clinical side effects Rash, spontaneous 
ecchymoses 
782.1, 782.7 
Poisonings By antibiotics and other 
antiinfectives  
960–961, E856–857 
Poisonings By hormones and synthetic 
substitutes  
962, E858.0 
Poisonings By primarily systemic 
agents 
963, E858.1 
Poisonings By agents primarily 
affecting blood constituents 
964, E858.2 
Poisonings By analgesics, antipyretics, 
antirheumatics 
965, E850 
Poisonings By anticonvulsant and anti-
Parkinsonian drugs 
966, E855.0 
Poisonings By sedatives and hypnotics 967, E851–852 
Poisonings By other central nervous 
system depressants, 
stimulants, anesthetics, 
nervous system agents 
968, E855.1–855.9 
Poisonings By psychotropic agents 969, E853–854 
Poisonings By other agents 969, E853–854 
Adverse effects Of antibiotics and other 
antiinfectives 
E930–931 
Adverse effects Of hormones and synthetic 
substitutes 
E932 
Adverse effects Of primarily systemic 
agents 
E933 
Adverse effects Of agents primarily 
affecting blood constituents 
E934 
Adverse effects Of analgesics, antipyretics, 
antirheumatics 
E935 
Adverse effects Of anticonvulsant and anti-
Parkinsonian drugs 
E936 
Adverse effects Of sedatives and hypnotics E937 
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ADE Type Class ICD9 Flag Code 
Adverse effects Of other central nervous 
system depressants, 
stimulants, anesthetics, 
nervous system agents 
E938, E940–941 
Adverse effects Of psychotropic agents E939 
Adverse effects Of agents primarily 
affecting the cardiovascular 
system 
E942 
Adverse effects Of other drugs, biological, 










Table 3. Hospital and Patient Characteristics by Advanced EHR Status 
 
 Total 













Age in years 48.3 (27.9) 49.4 (27.7) 45.9 (28.0) <0.0001 
Risk mortality 1.60 (0.88) 1.62 (0.88) 1.57 (0.87) <0.0001 
Risk severity 1.97 (0.91) 1.95 (0.91) 1.97 (0.91) <0.0001 
     
Adverse drug events 67,724 (6.6) 48,772 (6.7) 18,952 (6.3) <0.0001 
Medicaid 215,441 (20.9) 149,105 (20.4)    66,338 (22.1)  <0.0001 
Medicare 380,804 (36.9) 281,521 (38.5) 99,283 (33.1)  
Private insurance 343,188 (33.3) 237,420 (32.5) 105,768 (35.2)  
Other ins/self pay/no 
charge 
91,350 (8.9) 62,332 (8.5)  29,018 (9.7)  
Neonatal/maternal admit 235,592 (22.8) 162,799 (22.3) 72,793 (24.2) <0.0001 
Transfer into hospital 56,766 (5.5) 35,497 (4.9) 21,269 (7.1) <0.0001 
Race/Ethnicity     
     White 591,032 (57.2) 433,788 (59.3) 157,244 (52.2) <0.0001 
     Black 117,404 (11.4) 76,097 (10.4) 41,307 (13.7)  
     Hispanic 124,379 (12.0) 90,275 (12.3) 34,104 (11.3)  
     Other/missing 200,086 (12.0) 131,452 (18.0) 68,634 (22.8)  
Teaching hospital 504,828 (48.9) 310,797 (42.5)  194,031 (64.4) <0.0001 
Urban hospital 930,479 (90.1) 639,567 (87.4) 290,912 (96.6) <0.0001 
Small hospital 116,715 (11.3)  93,943 (12.8) 22,772 (7.6) <0.0001 
Medium hospital 248,545 (24.1) 170,981 (23.4)  77,564 (25.7)   
Large hospital 667,645 (64.6) 466,692 (63.8) 200,953 (66.7)  
Northeastern United 
States 
281,526 (27.3) 166,609 (22.8) 114,917 (38.1) <0.0001 
Midwestern United States 133,327 (12.9) 72,746 (9.9) 60,581 (20.1)  
Western United States 295,064 (28.6) 22,9429 (31.4) 65,635 (21.8)  





Table 4. Zero-Inflated Poisson Parameter Estimates  
 Poisson Binomial (Probability of zero medication errors) 
Variable Estimate 95% CI P Estimate 95% CI p 
Advanced EHRs 0.0095 -0.0052, 0.0242 0.2058 0.0045 0.0273, 0.0637 <0.0001 
Age -0.0101 -0.0105, -0.0096 <0.0001 -0.0008 -0.0013, -0.0002 0.0051 
Female  0.0784 0.0656, 0.0911 <0.0001 -0.0434 -0.0593, -0.0275 <0.0001 
Race       
     Black -0.5211 -0.5466, -0.4957 <0.0001 -0.3960 -0.4304, -0.3617 <0.0001 
     Hispanic -0.3660 -0.3930, -0.3390 <0.0001 0.0840 0.0521, 0.1160, <0.0001 
     Other/unknown -0.2649 -0.2870, -0.2427 <0.0001 -0.1527 -0.1803, -0.1250 <0.0001 
     White (ref) Ref      
Risk mortality -0.0059 -0.0164, 0.0047 0.2744 -0.1992 -0.2128, -0.1855 <0.0001 
Risk severity 0.0617 0.0502, 0.0732 <0.0001 -0.4464 -0.4603, -0.4325 <0.0001 
Neonatal or maternal admit -0.6434 -0.6886, -0.5982 <0.0001 1.4943 1.4482, 1.5404 <0.0001 
Teaching hospital 0.0871 0.0677, 0.1065 <0.001 0.1579 0.1336, 0.1822 <0.0001 
Hospital’s number of beds -0.0049 -0.0161, 0.0062 0.3841 0.0450 0.0311, 0.0589 <0.0001 
Urban vs. Rural location 0.1574 0.1272, 0.1876 <0.0001 0.1052 0.0672, 0.1432 <0.0001 
Insurance       
     Medicaid 0.0093 -0.0109, 0.0295 0.3669 -0.1367 -0.1610, -0.1124 <0.0001 
     Medicare 0.0217 0.0038, 0.0397 0.0178 0.0690 -0.0912, -0.0467 <0.0001 
     Other insurance/self-pay/no charge 0.0548 0.0315, 0.0780 <0.0001 -0.1392 -0.1671, -0.1112 <0.0001 
     Private Ref      
Geographic Region       
     Midwest 0.0999 0.0689, 0.1309 <0.001 -0.1725 -0.2114, -0.1336 <0.0001 
     Northeast -0.0197 -0.0466, 0.0072 0.1515 0.0760 0.0428, 0.1093 <0.0001 
     South -0.0763 -0.0942, -0.0584 <0.0001 -0.0178 -0.0400, 0.0044 0.1157 
     West Ref      
Transferred into hospital 0.0399 0.0215, 0.0582 <0.0001 <0.0001 0.1199, 0.1666 <0.0001 
Case Mix -0.0138 -0.0169, -0.0107 <0.0001 <0.0001 0.0735, 0.0817 <0.0001 
Propensity strata -0.0695 -0.0826, -0.0563 <0.0001 <0.0001 -0.0623, -0.0295 <0.0001 
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Table 5. Logistic Regression Parameter Estimates  
 Binomial (Probability of medication errors) 
Variable Estimate 95% CI P 
Advanced EHRs -0.0291 -0.0378, -0.0205 <0.0001 
Age -0.0077 -0.0079, -0.0075 <0.0001 
Female  0.1081 0.1006, 0.1155 <0.0001 
Race    
     Black -0.1545 -0.1669, -0.1422 <0.0001 
     Hispanic -0.3871 0.4015, 0.3726 <0.0001 
     Other/unknown -0.0992 -0.1110, -0.0874 <0.001 
     White (ref) Ref   
Risk mortality 0.1368 0.1306, 0.1429 <0.0001 
Risk severity 0.4214 0.4150, 0.4278 <0.0001 
Neonatal or maternal admit -1.9713 -1.9919, -.1.9506 <0.0001 
Teaching hospital -0.0494 -0.0606, -0.0382 <0.0001 
Hospital’s number of beds -0.0366 -0.0428, -0.0303 <0.0001 
Urban vs. Rural location 0.0590 0.0424, 0.0757 <0.0001 
Insurance    
     Medicaid 0.1238 0.1116, 0.1360 <0.0001 
     Medicare 0.0720 0.0614, 0,0826 <0.0001 
     Other insurance/self-pay/no charge 0.1527 0.1386, 0.1668 <0.0001 
     Private Ref   
Geographic Region    
     Midwest 0.3385 0.2108, 0.2462 <0.0001 
     Northeast -0.0828 -0.0982, -0.0675 <0.0001 
     South -0.0515 -0.0619, -0.0411 <0.0001 
     West Ref   
Transferred into hospital -0.0863 -0.0969, -0.0757 <0.0001 
Case Mix -0.0785 -0.0810, -0.0761 <0.0001 





Table 6. Base Estimate Propensity Strata and Matched Sample Proportions of 
Medication Errors Among Hospitals with and without Advanced EHR 
(Logistic Regression Model) 
 
 Base Estimate Propensity 
Strata (n=1,032,905) 
Base Estimate Propensity 
Matched Sample  
(n=61,390) 
Advance EHR 0.039 0.037 
No Advanced EHR 0.040 0.036 







Table 7. NPSF Recommendations for Achieving a Total Systems Approach and 




Ensure that leaders establish and sustain a safety culture. 
 
2. Create centralized and coordinated oversight of patient safety. 
 
3. Create a common set of metrics that reflect meaningful outcomes. 
 
4. Increase funding for research in patient safety and implementation science. 
 
5. Address safety across the entire care continuum. 
 
6. Support the health care workforce. 
 
7. Partner with patients and families for the safest care. 
 
8. Ensure that technology is safe and optimized to improve patient safety. 
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APPENDIX: ADDITIONAL DESCRIPTIVE SUMMARIES 
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Types of Medication Errors 
 
*Note: Percentage of admissions (or patient cases) with medication errors 
falling within each category. Categories are not mutually exclusive. Each 
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Age Distribution of Medication Errors  
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